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Saccharopine dehydrogenase (SDH) catalyses the NAD-dependent oxidative 
deamination of saccharopine to give L-lysine and α-ketoglutarate.  There are a number 
of conserved hydrophilic, ionizable residues in the active site, all of which must be 
important to the overall reaction.  In an attempt to determine the contribution to binding 
and rate enhancement of each of the residues in the active site, mutations of residues 
singly and in pairs are being made.  In this dissertation, the effects of mutation of active 
site residues, E78, E122, K99 and D319, on reactant binding and catalysis is reported.  
Site-directed mutagenesis was used to generate E78Q, E122Q, E78Q/E122Q, E78A, 
E122A, E78A/E122A mutant enzymes in the wild type back ground, and K99M and 
D319A in the C205S background.  Mutations of glutamates 78, 122 and D319, increase 
the positive charge while mutation on K99, decreases the positive charge in the active 
site, and as a result the pKa values of the catalytic groups were affected. Each mutant 
enzyme was completely characterized with respect to its kinetic and chemical 
mechanism.  The kinetic mechanism remains the same as that of wild type enzymes for 
all the mutant enzymes, with the exception of E78A, which exhibits binding of α-
ketoglutarate to E and E·NADH.  Large changes in V/KLys, but not V, suggest that E78, 
E122, K99 contribute binding energy for lysine. Shifts in the pKa values of the catalytic 
groups by more than a pH unit to higher and lower pH was observed for the V/KLys pH-
rate profile of the glutamate mutant enzymes suggesting that E78 and E122 modulate 
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the basicity of the catalytic groups. Changing K99 affected several kinetic parameters 
and this is consistent with its contribution to a hydrogen-bonding network in the active 
site. The largest change in V/KLys was observed for K99M which suggests it is crucial 
for lysine binding. Substantial changes observed for the second order rate constants 
V/KNADH and V/Kα-Kg, consistent with its contribution to a hydrogen bonding network in 
the active site. Mutation of D319 exhibited its largest effect on V/KNADH and KNADH, 
suggesting its contribution to binding NADH. No significant changes in V/Et was 
observed for K99 and D319 indicating they are not catalytic groups but are interactively 
involved in substrate binding. All ionizable residues studied thus far appear to be 








1-1. Essential amino acids 
All living organisms use 20 common amino acids for their protein synthesis. 
Arginine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, 
tryptophan and valine cannot be synthesized in mammalian cells, must be obtained from 
dietary sources, and are therefore called essential amino acids. The rest of the amino 
acids are synthesized in mammalian cells, and are termed nonessential amino acids. 
Evolution has obviated the capability of higher organisms to synthesize essential amino 
acids probably due to their readily availability in dietary sources. However, it is 
important to understand the biosynthetic pathways of the essential amino acids in plants 
and microorganisms. These pathways are more complicated than pathways for the 
synthesis of nonessential amino acids and they can be species-specific (1). 
Regulation of amino acid biosynthesis occurs at two levels. The first level of 
regulation takes place via gene expression while the second level of regulation takes 
place via enzyme activity and metabolic flux. Many of the regulatory studies of amino 
acid biosynthesis in prokaryotes have been carried out in Escherichia coli and 





1-2. Biosynthesis of L-lysine  
 The biosynthesis of L-lysine in various organisms is associated with an amazing  
diversity of pathways and enzymes involved in metabolism of this amino acid. Lysine is 
an essential amino acid and cannot be synthesized in humans and mammals (2, 3). It 
can only be synthesized de novo in bacteria, lower eukaryotes, and some plants (4). 
Two independent and distinct strategies of lysine biosynthesis, known as 
diaminopimelate (or DAP) and alpha-aminoadipate (or AAA) pathways, were initially 
characterized in bacteria and fungi, respectively (5-8). To date, no organism has been 
identified that possesses both pathways, suggesting an independent evolution of the two 
pathways. An elegant genomic survey of these pathways (4) reveals an intriguing 
evolutionary history, and their interrelationship with other metabolic pathways (like the 
TCA cycle, leucine and arginine biosynthesis), and also provide examples of 
dichotomous evolution within biosynthetic pathways (4). Among the 20 amino acids, L-
lysine is the only amino acid found thus far, to have two distinct pathways for its 
synthesis. In contrast to lysine synthesis, the synthesis of other amino acids is similar in 
bacteria and fungi (1, 9). 
 The diaminopimelic acid pathway (DAP) is common in bacteria, certain lower 
fungi (Hyphochitriales, Saprolegniales and Leptomytales) and green plants with the 
exception of blue green algae. In numerous groups of fungi, the distribution of DAP and 
AAA pathways has extensively been studied on both genetic and enzymatic levels. All 
fungi utilizing the DAP pathway exhibit a poorly defined cellulose cell wall, hydroxy 
proline instead of proline in their cell walls and catabolic repression of glutamate and 
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lactate dehydrogenases (3). None of the remaining fungal classes Phycomycetes, 
Ascomycetes, Deuteromycetes and Basidiomycetes, which utilize the AAA pathway for 
lysine biosynthesis, exhibit these characteristics. Moreover, the presence of cellulose in 
the cell walls is related to the DAP pathway, while chitin is related to the AAA pathway 
(2). Most of our genetic and biochemical understanding of the AAA pathway has 
resulted from studies of the yeast Saccharomyces cerevisiae with some information 
available for enzymes from Yarrowia lypolytica, Neurospora crassa and Candida sp. 
Aspartate is the common precursor for lysine biosynthesis in the DAP pathway while it 
is glutamate in the AAA pathway (4 -7). 
1-3. Diaminopimelic acid pathway  
 The enzymology, genetics and regulation of this pathway have been studied 
extensively in Escherichia coli (10, 11). DAP is a key component in bacterial 
peptidoglycan assembly and crosslinking. The enzymes of the diaminopimelate 
pathway are targets for the development of new antibiotics (12).  
 The DAP pathway is comprised of seven enzyme-catalyzed reactions (Scheme 
1-1) (1, 7). It belongs to the aspartate family of amino acid biosynthesis, since aspartate 
is a precursor of aspartate-β-semialdehyde. Lysine biosynthesis is initiated by 
phosphorylation of the β-carboxylate of aspartate by aspartokinase, to produce aspartyl-
β-phosphate followed by reductive phosphorolysis to aspartate-β-semialdehyde. An 
aldol condensation of aspartate-β-semialdehyde and pyruvate followed by cyclization 
gives 2,3-dihydrodipicolinate, which is then reduced by NADPH to ∆’-piperidine-2,6-
dicarboxylate. Succinylation (or acetylation) stabilizes the ring open form to give N-
succinyl (or acetyl) α-amino-ε-ketopimelate. The acyl group is removed after 
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transamination to yield L,L-DAP, which can be either incorporated directly into 
peptidoglycan or racemized to the meso form before incorporation. Racemization to the 
























































Scheme 1-1. Enzymes of the DAP pathway for lysine biosynthesis: i, aspartate kinase 
[EC 2.7.2.4]; ii, aspartate semialdehde dehydrogenase [EC 1.2.1.11]; iii, 
dihydropicolinate synthase [EC 4.2.1.52] dihydropicolinate reductase [EC 1.3.1.26 v, 
tetrahydrodipicolinate acyltransferase [EC 2.3.1.117];  vi, N-succinyl-α-amino-ε-
ketopimelate-glutamate aminotransaminase [EC 2.6.1.17]; vii, N-acyldiaminopimelate 
deacylase [EC 3.5.1.18], [EC 3.5.1.47]; viii, DAP epimerase [EC 5.1.1.7], ix, DAP 
decarboxylase [EC 4.1.1.20] (13). 
 
1-4. The α-aminoadipate pathway 
Tha α-aminoadipate pathway (AAA) is used for biosynthesis of lysine only in 
higher fungi including Phycomycetes (Chytridiales, Blastocladiales and Mucorales), 
(Ascomycetes and Basidiomycetes), blue green algae (cyanobacteria) and Euglenids (7, 
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14, 15). In higher fungi, the lysine biosynthetic pathway stems from α-ketoglutarate, 
and it is thus in the class of glutamate amino acids (9). 
 The presence of the AAA pathway for lysine biosynthesis has been found in 
several yeasts and molds, including S. cerevisiae (16, 17), Yarrowia lipolytica (18), 
Schizosaccharomyces pombe (19), Rhodotorula glutinis (20), Candida maltosa (21), 
Neurospora crassa (22), and Penicillium chrysogenum (23), the human pathogens 
Candida albicans (24), Cryptococcus neoformans, and Aspergillus fumigatus (25), and 
the plant pathogen Magnaporthe grisea (1, 25). The enzymes from C. albicans and A. 
fumigatus show high similarity to their closest homologs from S. cerevisiae. Multiple 
sequence alignments exhibit more than 60% identity for all the enzymes, with the 
exception of the aminotransferase (see Scheme 1-2).  




Homocitrate synthase (Lys20, Lys21) LYS20 (cytosol), LYS21 (Mitochondria) 
Homoaconitase (Lys4, Lys7) LYS4, LYS7 
Homoisocitrate dehydrogenase (Lys12) LYS12 
α-Aminoadipate aminotransferase  - 
α-Aminoadipate reductase (Lys2) LYS2 
Saccharopine reductase (Lys9) LYS9 (regulated by LYS14)  
Saccharopine dehydrogenase (Lys1) LYS1 
 
*Genes are denoted in upper case italic letters and the gene products are 





The S. cerevisiae genome has completely been sequenced (26, 27), and 
extensive genetic, enzymatic and regulatory studies of the lysine biosynthetic pathway 
are being carried out in S. cerevisiae. Seven enzymes, eight steps and more than 12 non-
linked genes are involved in lysine biosynthesis in yeast. Genes and their encoded 
enzymes are listed in the Table 1-1. The de novo synthesis of lysine in fungi is shown in 
Scheme 1-2. The enzymatic steps are briefly discussed below and numbers refer to 
Scheme 1-2. 
The AAA pathway is initiated by homocitrate synthase (HCS), with the 
condensation of α-ketoglutarate (α-Kg) and acetyl CoA to give the intermediate 
homocitryl CoA (I), which is then hydrolyzed by the same enzyme to give homocitrate. 
Then, homocitrate is converted by homoaconitase (HAc), via the intermediacy of 
homoaconitate to give homoisocitrate (II, III). Homoisocitrate dehydrogenase (HIcDH) 
then oxidatively decarboxylates homoisocitrate to generate α-ketoadipate (IV), which is 
converted to α-aminoadipate (AAA), by a pyridoxal 5´-phosphate (PLP) dependent 
aminotransferase (AAT), using L-glutamate as the amino donor (V). α-Aminoadipate is 
converted to α-aminoadipate-δ-semialdehyde (AAS), by α-aminoadipate reductase 
(AAR) (VI). α-Aminoadipate-δ-semialdehyde is then condensed with glutamate, and 
saccharopine reductase (SR) reduces the imine, using NADPH to give L-saccharopine 
(VII). Finally, the oxidative deamination of saccharopine is catalyzed by Saccharopine 
dehydrogenase (SDH) to give L-lysine (VIII). 
The first half of the AAA pathway, formation of α-aminoadipate, takes place in 
the mitochondrion (28); homocitrate may also be synthesized in the nucleus and 
cytoplasm.  The second half of the pathway, conversion of α-aminoadipate to L-lysine 
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occurs in the cytosol. The mitochondrial pathway for synthesis of L-α-aminoadipate 
shares many similarities with the tricarboxylic acid cycle (TCA) but the early 
intermediates of the lysine pathway are one carbon higher homologs, e.g., homocitrate 
compared to citrate. The reasons for the AAA-pathway to occur in two different 




























































Scheme 1-2. Enzymes of the fungal α-aminoadipate pathway: I, homocitrate synthase 
[EC 4.1.3.21]; II & III, homoaconitase [EC 4.2.1.36]; IV, homoisocitrate dehydrogenase  
[EC 1.1.1.87]; V, aminoadipate aminotransferase EC 2.6.1.39; VI, aminoadipate 
reductase [EC 1.2.1.31]; VII, saccharopine reductase [EC 1.5.1.10]; VIII, saccharopine 




or adenosine triphosphate (ATP), or the pH that gives an optimum protonation state to 
catalyze reactions involved in the pathway (28). 
There are also cases where α-aminoadipate pathway intermediates are 
incorporated into secondary metabolites. In Penicillium chrysogenum, α-aminoadipate 
is incorporated into ACV (L-δ-(α-aminoadipoyl)-cystein-D-valine), a linear tripeptide 
precursor to penicillin in the tripeptide synthetase step (7, 29), and as a precursor of the 
essential amino acid lysine. In addition, the product α-aminoadipate can serve as a sole 
nitrogen source for Filobasidiella neoformans, S. pombe, C. albicans, and A. fumigatus 
(30).  
The route for lysine synthesis requires reduction of the C6 carboxylate of α-
aminoadipate. The reduction occurs via the action of α-aminoadipate reductase which is 
the product of the LYS2/LYS5 genes to yield α-aminoadipate semialdehyde. α-
Aminoadipate semialdehyde is then condensed with glutamate to form saccharopine 
which is then converted to give lysine and α-ketoglutarate, the final products (31). 
Lysine biosynthesis in yeast requires the posttranslational conversion of the α-
aminoadipate semialdehyde reductase (Lys2) by the 4´-phosphopantetheinyl transferase 
(PPTase) (Lys5) from the inactive apo-form into the catalytically active holo-form (16, 
32). 
 
1-4-2. Regulation of the α-aminoadipate pathway 
The AAA pathway is highly regulated at both genetic and enzyme activity levels 
(16). The pathway is genetically regulated by the general mechanism for the control of 
amino acid biosynthesis. It is also regulated by a pathway specific co-inducer-dependent 
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transcriptional activation. The co-inducer is α-aminoadipate-δ-semialdehyde (AAS), 
which is an intermediate in the pathway (28, 33-35). In S. cerevisiae, expression of the 
lysine genes can be stimulated by Lys14p when AAS is present (33). The co-inducer 
AAS is also produced under control of the metabolic flux, mediated by feedback 
inhibition by lysine on homocitrate synthase (HSC), the first enzyme of the pathway 
(36, 37). Thus, lysine can suppress the expression of its own biosynthetic genes. The 
synthesis of the six enzymes of the pathway can also be repressed by excess lysine (16, 
37). A mechanism has been proposed to interrelate these two types of regulation (38). 
Several mutations in the HCS genes (LYS20 or LYS21) rendered S. cerevisiae 
insensitive to lysine feedback inhibition (38). Up to a 10- fold increase in the lysine 
production was observed upon transformation of these mutant genes. According to these 
results, HCS plays a significant role in the repression of the lysine biosynthetic 
enzymes. LYS9 (saccharopine reductase) and LYS14 (transcriptional activator) are two 
unlinked genes required for producing saccharopine in S. cerevisiae (1). Mutation of 
LYS9 results in lysine auxotrophy, and lack of aminoadipate reductase activity. 
Mutations of LYS14 resulted in slow growth, with a stunted reductase activity when 
lysine was absent in yeast. Lys14p is mandatory for the expression of the LYS9 gene. It 
plays a regulatory role with AAS as the co-inducer of transcriptional activation. 
Therefore, low levels of SR activity in LYS14 mutants can be explained by weak 
expression of LYS9 in the absence of the co-inducer, AAS (4, 33). 
 An upstream activating sequence (UAS) has been recognized in the promoter 
regions of the LYS1 (SDH) and LYS9 (SR) genes of S. cerevisiae, for binding Lys14p. 
The UAS for activating these two genes contain TCC and GGA separated by 3-bp. One 
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or more copies of this 9-bp sequence have been identified in the promoter of at least 
four other LYS genes which include LYS20 (cytosolic HCS), LYS21 (mitochondrial 
HCS), LYS2 (AAR) and LYS4 (HAc) (35). It is also possible that other enzymes in the 
pathway, acting in a manner similar to HCS, may contribute to rate limitation in the 
regulation of lysine synthesis in S. cerevisiae, as suggested by the presence of at least 
one additional slow step between the HCS and AAR catalyzed reactions in P. 
chrysogenum (39). 
 
1-4-3. Significance of the α-aminoadipate pathway 
 Numerous fungal peptides and alkaloids contain lysine as a structural element or 
biosynthetic precursor. In addition to that, in certain fungi, a number of AAA pathway 
intermediates are incorporated into secondary metabolites. Human pathogenic fungi 
Candida albicans, Aspergillus fumigates, Cryptococcus neoformans and the plant 
pathogen Magnaporthe grisea use the AAA pathway for their lysine synthesis. 
 
1-4-3-1. Candida albicans 
C. albicans is a diploid fungus which causes oral and genital infections in 
humans (40, 41). It is normally present on the skin and in mucous membranes such as 
the vagina, mouth, or rectum. Candida lives in 80% of the human population, 
coexisting in our bodies with many species of bacteria in a competitive balance, with no 
harmful effects. Other bacteria act in part to keep Candida growth in check, in our body 
ecology unless that balance is upset. Overgrowth of Candida causes candidiasis. When 
a person is healthy, the immune system keeps Candida proliferation under control; but 
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when immune response is weakened, Candida growth can proceed unhindered (40). 
Most of the time, Candida infections of the mouth (oral thrush), skin, or vagina 
(vaginitis), occur for no apparent reason. The fungus also can travel through the blood 
stream and affect the throat, intestines, and heart valves. A common cause of infection 
may be the use of antibiotics that destroy beneficial, as well as harmful, microorganisms 
in the body, permitting Candida to multiply in their place. Systemic fungal infections 
have emerged as important causes of morbidity and mortality in immunocompromised 
patients with AIDS, cancer, undergoing chemotherapy, organ or bone marrow 
transplants. In addition, hospital-related infections in patients not previously considered 
at risk (e.g., patients in an intensive care unit) have become a cause of major health 
concern (40, 41). 
 
1-4-3-2. Aspergillus fumigatus 
Aspergillus fumigatus spores are ubiquitous in the atmosphere and it is estimated 
that everybody inhales several hundred spores each day; typically these are quickly 
eliminated by the immune system in healthy individuals.  This fungus usually grows at 
37 °C, and can grow at temperatures up to 50 °C, with conidia surviving at 70 °C. 
 Aspergillus fumigatus is one of the most common Aspergillus species and it causes a 
deadly disease called aspergillosis, a lung infection in immunocompromised patients. 
There has been a dramatic increase in severe and invasive aspergillosis, and it is now 





1-4-3-3. Cryptococcus neoformans 
Cryptococcus neoformans is an encapsulated fungal organism. Infection with C.  
neoformans is termed cryptococcosis. Most infections with C. neoformans consist of a 
lung infection (43). However, fungal meningitis, especially as a secondary infection for 
AIDS patients, is often caused by C. neoformans making it a particularly dangerous 
fungus. Infections with this fungus are rare in those with fully functioning immune 
systems. For this reason, C. neoformans is referred to as an opportunistic pathogen (44). 
 
1-4-3-4. Magnaporthe grisea 
Magnaporthe grisea, known as rice blast fungus among other names, is a plant-
pathogenic fungus that causes a disease affecting rice. Members of the Magnaporthe 
grisea complex can also infect a number of other agriculturally important cereals 
including wheat, rye, barley, and pearl millet causing blast disease or blight disease. 
Rice blast causes economically significant crop losses, and it is estimated to destroy 
enough rice to feed more than 60 million people annually. The fungus is known to occur 
in 85 countries worldwide (45). 
 
1-4-3-5. Current antifungal drugs 
  There are many antimycotics already used to treat fungal infections. Among 
them are polyenes (Natamycin, Rimocidin, Amphotericin B, Candicin etc), azole based 
drugs (Miconozole, Fluconazole, Itraconazole, Abafungin etc.), allylamines, 
echinocandins and several others.  Antifungals work by exploiting differences between 
mammalian and fungal cells to kill the fungal organism without dangerous effects to the 
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host. Unlike bacteria, fungi and humans are eukaryotes, thus fungal and human cells are 
similar at the molecular level. This makes it more difficult to find or design drugs that 
target fungi without affecting human cells. Consequently, many antifungal drugs cause 
side-effects. Some of these side-effects can be life-threatening if the drugs are not used 
properly. Apart from side-effects like liver-damage or affecting estrogen levels, many 
medicines can cause allergic reactions, and can lead to anaphylaxis (46).  
There are also many drug interactions (47). For example, the azole antifungals 
such as ketoconazole or itraconazole can be both substrates and inhibitors of the P-
glycoprotein, which (among other functions) excretes toxins and drugs into the 
intestines (46). Resistance to current antimycotics has increased during the last 10 years, 
reflecting increased incidence of immunodeficiency associated with cancer 
chemotherapy, organ and bone marrow transplantation, and the HIV epidemic (48, 49). 
Although the prevalence of drug resistance in fungi is below that observed in bacteria, 
many mycologists consider that selective pressure will, lead to more widespread 
resistance over time (48). The search for new antifungal drugs, which can overcome the 
existing drawbacks, is inevitable.  
All the above opportunistic fungi target patients with a suppressed immune 
system. Sequence alignment data for SDH from the above pathogenic fungi, indicate 
more than 65% sequence identity to the SDH from S. cerevisiae. The uniqueness of the 
AAA pathway to fungi and euglenoids makes it a target for the rapid detection and 
control of pathogenic yeasts and molds (4, 50, 51). Knocking out the LYS1 gene is lethal 
to fungi suggesting that, selective inhibition of one or more enzymes, may help to 
control or completely eradicate these pathogens in vivo (19, 24).  Therefore it is 
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important to understand the mechanism of enzymes and inhibition patterns in order to 
develop potential new antifungal drugs in the future. 
 
1-4-4. Enzymes of the α-aminoadipate pathway 
1-4-4-1. Homocitrate Synthase (HCS) 
HCS initiates the pathway by catalyzing the first and committed step, a Claisen  
condensation of acetyl CoA and α-ketoglutarate to give the enzyme bound intermediate 
homocitryl CoA, which is hydrolyzed by the same enzyme to give homocitrate. HCS 
belongs to the family of transferases, specifically those acyltransferases that convert 
acyl groups into alkyl groups on transfer. The condensation is reversible but the product 
is trapped by hydrolysis of the acyl CoA. This reaction is thought to be the rate limiting 
step of the pathway. It is highly regulated to conserve the use of resources. There are 
two isozymes of HCS, one present in the mitochondria and the other one in cytosol. 
Both isozymes have also been reported found in nucleus, but neither isozyme exhibited 
a signal sequence nor a canonical sequence directing them to the mitochondrion or 
nucleus (52). 
HCS is not stable when isolated, but the HCS from S. cerevisiae has been 
stabilized using 100 mM guanidine hydrochloride, 100 mM α-cyclodextrin and 600 mM 
ammonium sulfate (25). HCS from S. cerevisiae exhibits an ordered Bi-Bi kinetic 
mechanism, where α-Kg binds to the enzyme first followed by acetyl-CoA, and CoA is 
released before homocitrate (53). HCS is feedback inhibited by L-lysine, which is the 
end product of the pathway. 
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The crystal structures of HCS have been solved for the apo-enzyme and two 
distinct structures of the enzyme in complex with the substrate α-ketoglutarate, from 
Schizosaccharomyces pombe. In one structure, a lid motif from the C-terminal domain 
occludes the entrance to the active site of the neighboring monomer, while in the second 
structure, the lid is disordered. The structures reveal that HCS forms an intertwined 
homodimer that is stabilized by domain-swapping between the N- and C-terminal 
domains of each monomer (54). HCS is a metalloenzyme that utilizes Zn2+ (55). 
According to the proposed chemical mechanism of HCS, α-Kg first binds to the active 
site Zn2+ via its α-carboxylate and α-keto groups, followed by acetyl-CoA. A general 
base then accepts a proton from the methyl of acetyl-CoA, and a general acid protonates 
the carbonyl of α-Kg in the formation of homocitryl-CoA. The general acid then acts as 
a base in deprotonating Zn-OH2 in the hydrolysis of homocitryl-CoA to give 
homocitrate and CoA. The condensation to give the alkoxide of homocitryl-CoA, is 
considered the rate limiting step (55). 
 
1-4-4-2. Homoaconitase (HAc) 
Homoaconitase (HAc) [EC 4.2.1.36], also known as homoaconitate hydratase,  
belongs to the family of lyases, specifically the hydro-lyases, which cleave carbon-
oxygen bonds. HAc contains one FeS cluster and catalyzes the second and the third step 
of the pathway, the interconversion of homocitrate and homoisocitrate via the 
intermediate homoaconitate. HAc is a member of the aconitase superfamily, which 
includes isopropyl malate isomerase, a member of the leucine biosynthetic pathway in 
bacteria and fungi, and aconitases. It is a mitochondrial enzyme that is repressed by 
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lysine and glucose (4). Little is known of the mechanism of HAc, but it is likely very 
similar to that of aconitase (13). 
 
1-4-4-3. Homoisocitrate Dehydrogenase (HIcDH) 
Homoisocitrate dehydrogenase belongs to the family of oxidoreductases, 
specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as 
acceptor.  HIcDH [EC 1.1.1.87] catalyses the fourth step of the pathway, which is a 
Mg2+ and K+ dependent oxidative decarboxylation of homoisocitrate to α-ketoadipate 
using NAD+ as the oxidant. HIcDH belongs to the well studied, pyridine nucleotide-
linked β-hydroxyacid oxidative decarboxylase family (56). The crystal structure of 
homoisocitrate dehydrogenase from Thermus thermophilus (TtHIcDH) has been 
determined to 1.85 Å resolution (57). 
The proposed chemical mechanism of HIcDH suggests two enzyme groups act 
as acid-base catalysts in the reaction. A group with a pKa of approximately 6.5-7 acts as 
a general base accepting a proton as the β-hydroxy acid is oxidized to the beta-keto 
acid, and this residue participates in all three of the chemical steps, acting to shuttle a 
proton between the C2 hydroxyl and itself. The second group acts as a general acid has 
a pKa of 9.5 and likely catalyzes the tautomerization step by donating a proton to the 
enol to give the final product. Isotope effects indicate that the hydride transfer and 
decarboxylation steps contribute to rate limitation, and that the decarboxylation step is 
the more rate-limiting of the two. Isotope effects also suggest a stepwise mechanism 




1-4-4-4. α-Aminoadipate Aminotransferase (AAT) 
α-Aminoadipate aminotransferase [EC 2.6.1.39] is a (PLP)-dependent enzyme, 
that catalyzes the fifth step, conversion of α-ketoadipate  to α-aminoadipate, using L-
glutamate as the amino donor. In S. cerevisiae, two isozymes of aminotransferase have 
been identified and isolated (4, 59, 60), one in mitochondrian and the other in the 
cytosol.  Only the cytosolic isozyme seems to be specific to the AAA pathway.  The 
AAT reaction is also a branch point to secondary metabolism, in P. chrysogenum 
including the de novo synthesis of β-lactam antibiotics for penicillin (7, 61). The 
product, α-aminoadipate (AAA) can also serve as a solitary nitrogen source for 
Filobasidiella neoformans, S. pombe, C. albicans, and A. fumigatus (30).  
 
1-4-4-5. α-Aminoadipate Reductase (AAR) 
 In the cytoplasm, α-aminoadipate reductase [EC1.2.1.31] catalyses the reduction 
of AAA to give α-aminoadipate-δ-semialdehyde (AAS), a unique process which 
involves both adenylation and reduction that is found only in fungi. AAR must be 
activated by a phosphopantetheinyl transferase (PPT). The AAA-catalyzed reaction is 
thought to be a three step process. First, the amino acid reacts with ATP to form an 
adenylyl derivative. In the second step, the reduction of the adenylyl derivative, AAA 
by NADPH takes place. In the final step, the reduced adenylyl derivative is cleaved by 
the amino acid to form AAS. The first and the second steps require Mg-ATP and 
NADPH, respectively (62). 
In Saccharomyces cerevisiae, the enzymatic reduction of α-aminoadipate at C6 
to the semialdehyde, requires two gene products, Lys5 (31 kDa) and Lys2 (155 kDa). 
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Studies have shown, using CoASH as a cosubstrate, that the Lys5 is a specific 
posttranslational modification catalyst, to phosphopantetheinylate Ser880 of the Lys2, 
and activate it for catalysis (63). Lys2 was expressed as a full-length 155-kDa enzyme, 
as a 105-kDa adenylation/peptidyl carrier protein (A-PCP) fragment (residues 1-924), 
and as a 14-kDa PCP fragment (residues 809-924). The A-PCP fragment was covalently 
modified to phosphopantetheinylated holo-PCP by pure Lys5 and CoASH. The 
adenylation domain of the A-PCP fragment activated S-carboxymethyl-L-cysteine at 
16% the efficiency of L-α-aminoadipate. The holo form of the A-PCP fragment of Lys2 
covalently aminoacylated itself with 35S-carboxymethyl-L-cysteine. Addition of 
NADPH discharged the covalent acyl-S-PCP Lys2, consistent with a reductive cleavage 
of the acyl-S-enzyme intermediate. These results identify the Lys5/Lys2 pair as a two-
component system in which Lys5 covalently primes Lys2, allowing α-aminoadipate 
reductase activity by holo-Lys2 with catalytic cycles of autoaminoacylation and 
reductive cleavage. This is a novel mechanism for a fungal enzyme essential for amino 
acid metabolism (63, 64). Structural information of AAR is not available at this time. 
 
1-4-4-6. Saccharopine Dehydrogenases: 
1-4-4-6-1.  Saccharopine Dehydrogenase (L-glutamate forming) 
Saccharopine dehydrogenase (L-glutamate forming), also known as 
saccharopine reductase [EC 1.5.1.10], belongs to the family of oxidoreductases, 
specifically those acting on the CH-NH group of donors with NAD+ or NADP+ as the 
oxidant. SR is also known as aminoadipate semialdehyde-glutamate reductase. It 
catalyzes the reversible condensation of AAS with L-glutamate to produce L-
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saccharopine, using NADPH as the reducing agent (65, 66) (Scheme 3). The structure 
of SR has been solved from S. cerevisiae (65) and Magneporthe grisea (66).  
 The kinetic mechanism of SR at pH 7, is sequential with ordered addition of 
NADPH to the free enzyme followed by L-α-aminoadipate-δ-semialdehyde which adds 
in rapid equilibrium prior to L-glutamate, in the physiologic reaction direction. In the 

















NADP+   + H2O
 
  L-glutamate       α-aminoadipate-δ-semialdehyde                       saccharopine 
Scheme 1-3. Reaction catalyzed by saccharopine reductase, in the physiological 
reaction direction. 
 
An acid-base chemical mechanism has been proposed for SR on the basis of pH-
rate profiles and solvent deuterium kinetic isotope effects. Two groups are involved in 
the acid-base chemistry. One of these groups catalyzes the steps involved in imine 
formation between the α-amine of glutamate and the aldehyde of AASA. The group, 
which has a pKa of about 8 must be protonated for optimal activity. The second group, 
which has a pKa of 5.6, must be unprotonated for optimal activity, and accepts a proton 
from the alpha-amine of glutamate so that it can act as a nucleophile in forming a 
carbinolamine upon attack of the carbonyl of AASA. Proton(s) are in flight in the rate-
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limiting step(s) and likely the same step is involved at limiting and saturating substrate 
concentrations. Proton inventories suggest that more than one proton is transferred in a 
single transition state, likely a conformation change required to open the site and release 
products (68). 
 
1-4-4-6-2.  Saccharopine Dehydrogenase (L-lysine forming) 
Saccharopine dehydrogenase (L-lysine forming), also known as lysine-2-
oxoglutarate reductase, catalyzes the final step of the AAA pathway, the oxidative 
deamination of saccharopine to give L-lysine. Saccharopine is a stable intermediate 
(13). The SDH is the focus of this dissertation and background on its structure and 
mechanism will be discussed in detail in the section 1-5. 
SR and SDH are specific to fungi and catalyze very similar reactions utilizing 
saccharopine as a common substrate, despite the fact that they show very little sequence 
homology at the amino acid level and have very different structures. These two 
enzymes use NADPH and NADH coenzymes respectively. A high NADPH-to-NADH 
ratio may favor the synthesis of lysine from aminoadipate semialdehyde where as a low 
ratio would favor the reverse reaction (13). 
 
1-5. Saccharopine dehydrogenase (L-lysine forming) 
1-5-1. General information 
 Saccharopine dehydrogenase [N6-glutaryl-2)-L-lysine: NAD+ oxidoreductase 
(L-lysine forming); EC 1.5.1.7] catalyzes the final step of the AAA pathway for lysine 
biosynthesis. It catalyzes the reversible pyridine nucleotide dependent oxidative 
21 
 
deamination of saccharopine to give α-ketoglutarate and lysine using NAD+ as the 
oxidizing agent (Scheme 1-4). SDH from S. cerevisiae is a monomer with a molecular 
mass 41 kDa. It is a basic protein with a pI of 10.1, and is stable for months at -20°C at 
concentrations greater than or equal to 0.1 mg/ml and a pH of 5.0-8.0 (69). One SDH 




Scheme 1-4. Reaction catalyzed by saccharopine dehydrogenase, in the physiological 
reaction direction. 
 
The LYS1 gene has been cloned from C. albicans (24), S. cerevisiae (50) and 
Schizosaccharomyces pombe (71), and the Km values for NAD+, saccharopine, lysine, α-
Kg and NADH are 0.9, 6.7, 1.1, 0.11, and 0.019 respectively (50). 
 
1-5-2. Substrate specificity 
 A number of studies, carried out in order to define the substrate specificity of 
NADH, α-Kg, and lysine analogues have revealed that SDH from S. cerevisiae shows 
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strict substrate specificity  with respect to its amino acid and keto acid substrates and 
cofactor (72-74).  
1-5-2-1. NAD+ and NADH analogues 
 Several NAD+ analogues (Figure 1-1), including NADP, 3-acetylpyridine 
adenine dinucleotide (3-APAD), 3-pyridinealdehyde adenine dinucleotide (3-PAAD), 
and thionicotinamide adernine dinucleotide (thio-NAD), can serve as a substrate in the 




Figure 1-1. Substrate and inhibitory analogs of NAD+. Structures given in boxes exhibit 
substrate activity when they are used in place of NAD+, while the other analogs are 




In the direction of saccharopine formation, the enzyme demonstrates a high level 
of cofactor specificity (72, 75). NADH is greatly preferred although it does use NADPH 
as a poor substrate, with a very low affinity (30). Moreover, binding of NADPH, 
increases Km values for α-Kg and lysine (76). Although coenzyme fragments, AMP, 
ADP, ADP-ribose, and ATP inhibit the enzyme activity, there was no inhibition 
observed by adenine, 3׳-AMP, 2׳-deoxy-5׳-AMP, IMP, GMP, NMN+ and NMNH (76). 
Inhibition studies using dinucleotide analogues suggest that the AMP portion provides 
most of the dinucleotide binding energy, and binding of NAD+ and NADH generates 
two distinctly different conformations (74). The low affinities of NADPH and lack of 
inhibition by 2׳-deoxy-5׳-AMP suggest that the interaction of the oxygen at the 2׳ 
position of the adenosine moiety with the enzyme is important in binding. The 
nicotinamide binding pocket is largely hydrophilic (74).  
 
1-5-2-2.  Keto acid substrate analogues 
 A number of aliphatic and aromatic keto acid analogues (Figure 1-2), have been 
used to study their inhibition patterns in order to obtain more information about the keto 
acid binding pocket. Data suggest that glyoxylate, pyruvate, α-ketobutyrate, α-
ketovalerate, α-ketomalonate and α-ketoadipate can serve as alternative substrates for α-
Kg in the oxidative deamination reaction but the side chains  with three carbons (from 
the keto group up, including the side chain carboxylate), is the optimal length for 
affinity. If the chain length is increased or decreased by one or more methylene(s), the 







Figure 1-2. Substrate and inhibitory analogues of α-Kg or the glutamyl portion of 
saccharopine: (A) substrate analogues, and (B) Competetive inhibitors. The portion of 
saccharopine in the dotted box is mimicked by the inhibitors. [reproduced with 
permission from Xu. et al, Biochemistry (2007), 46, 7625-7636]. 
 
1-5-2-3. Amino acid substrate analogues 
 Lysine is the only reported amino acid substrate for this enzyme. Inhibitory 
analogues of L-lysine (Figure 1-3) reveal that the lysine binding pocket is hydrophobic, 
and it can accommodate a branch at the γ-carbon, but not at the β-carbon. A three or 
four carbon long hydrophobic portion would be the optimum length for better 







Figure 1-3. Inhibitory analogues of L-lysine portion of saccharopine. The portion of 
saccahropine in dotted box is mimicked by inhibitors. [reproduced with permission 
from Xu. et al, Biochemistry (2007), 46, 7625-7636]. 
 
1-5-3. Kinetic mechanism 
 A  kinetic  mechanism (Scheme 1-4) for SDH was  proposed  as  random  Bi-Ter  
mechanism, with NAD+ binding first followed by saccharopine, in the physiological 
reaction direction (4, 50, 73, 77). Data also indicate that NADH adds to the enzyme 
first, while lysine and α-Kg add in a random fashion. In the opposite direction data also 
suggests that high concentrations of lysine inhibit the reaction by binding to the free 
enzyme, and competing with NAD+ (50). 
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The fact that all substrates must bind to the enzyme, before any products are 
released, indicates that the enzyme has separate binding sites for the coenzyme, keto 
and amino acid substrates. An ordered ter-reactant mechanism has been observed with 
pyruvate as a substrate, in the direction of ε-N-(L-propinyl-2)-L-lysine formation, but 
with an order, NAD+, ε-N-(L-propinyl-2)-L-lysine, pyruvate, lysine, and NADH. 
Reversal in the order of release of lysine and the keto acid is consistent with 
randomness in substrate binding in the mechanism (50, 78). 
 
1-5-3-1.  Substrate inhibition 
Many other pyridine nucleotide dehydrogenases that have an ordered kinetic 
mechanism exhibit substrate inhibition.  Analysis of the inhibition patterns of SDH 
from S. cerevisiae indicate inhibition by lysine and ketoglutarate at high concentrations, 
in the direction of saccharopine formation, but not by saccharopine in the direction of 
lysine forming (50, 77). Uncompetitive substrate inhibition by α-Kg and double 
inhibition by NAD+ and α-Kg suggests the existence of an abortive E·NAD·α-Kg 
complex (see Scheme 1-4). 
 
1-5-3-2.  Product inhibition 
Product inhibition data (see Scheme 1-4) reveals the order of product release. 
Competitive inhibition by NAD+ vs NADH at low lysine and α-Kg indicates NAD+ is 
the last product released, and noncompetitive inhibition by NAD+ vs lysine or α-Kg, 
indicates the binding of the nucleotide substrate to free enzyme (50). Noncompetitive 
inhibition by saccharopine vs lysine or α-Kg, suggests the existence of both 
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E·NADH·saccharopine and E·NAD+·saccharopine complexes. Uncompetitive product 
inhibition is observed by saccharopine vs NADH, likely resulting from the inability of 
the saccharopine to fully reverse the reaction at pH 7, consistent with the overall Keq 
3.9×10-7 M (50). 
 
1-5-3-3.  Dead-end inhibition 
 
 
Scheme 1-5: Proposed kinetic mechanism for the SDH. E represents the SDH. Kinetic 
data suggests that the reaction is irreversible in agreement with the Keq of the reaction. 
Inhibitor(s) with in paranthesis all bind to the same enzyme form as does Lys (50). 
[reproduced with permission from Xu et al, (2006) Biochemistry, 45, 12156-12166]. 
 
Dead-end inhibition patterns support the random addition of α-Kg and lysine. 
Oxalylglycine and leucine were used as the dead-end analogues of α-Kg and lysine, 
respectively. Both are uncompetitive against NADH and noncompetitive against lysine 
and α-Kg, respectively. Oxaloacetate, pyruvate, and glutarate behaves as dead-end 
analogues of lysine which suggests that the lysine binding site has a higher affinity for 
keto acid analogues than does the α-Kg site or that dicarboxylic acids have more than 
one binding mode on enzyme. In addition, OAA and glutarate bind to free enzyme as 
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does lysine at high concentrations. Glutarate gives S-parabolic noncompetitive 
inhibition vs NADH, indicating the formation of  a E.(glutarate)2 complex as a result of  
occupying both the lysine and α-Kg binding sites. Pyruvate, a slow alternative keto acid 
substrate exhibits competitive inhibition vs both lysine and α-Kg suggesting the 
combination to the E·NADH·α-Kg and E·NADH·lysine enzyme forms (61). See 
Scheme 1-5). 
 
1-5-4. Proposed Chemical mechanism 
SDH is pro-R specific for hydride transfer from C-2 of the saccharopine glutaryl 
moiety to the nicotinamide ring of NAD+ (77, 79). A series of chemical modification 
experiments suggested the presence of essential cysteine (70), histidine (80), lysine 
(81), and arginine residues (82) that may be involved in substrate binding and/or 
catalysis. A proton shuttle chemical mechanism has been proposed, for SDH from S. 
cerevisiae on the basis of pH-rate profiles, product and dead-end inhibition patterns and 
isotopic effect data (84). 
The proposed chemical mechanism (Scheme 1-6), suggests that in the direction 
of lysine formation, once NAD+ and saccharopine are bound, a group with pKa of 6.2 
accepts a proton from the secondary amine of saccharopine as it is oxidized (I). The 
conjugate acid of this base does not participate in the reaction further until lysine is 
formed at the end of one reaction cycle. The newly formed imine of saccharopine (II), is 
then hydrolyzed via a general base catalyzed activation of a water molecule, via 
carbinolamine intermediates (III, IV). The base (B2) participating in the hydrolysis 
reaction has a pKa of 7.2. Collapse of the carbinolamine is promoted by the same group 
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that accepted a proton from the carbinolamine hydroxyl, shuttling a proton between the 
reactant and itself to produce lysine and α-Kg (V). The side chain amine of lysine is 
ultimately protonated by the conjugate acid of B1 to release products (VI) (83, 84). 
 
 
Scheme 1-6: Proposed proton shuttle chemical mechanism (13) for Saccharopine 
dehydrogenase (L-lysine forming): I, central complex E:NAD:saccharopine after NAD+ 
and Saccharopine binding; II, Schiff base intermediate; III, carbinolamine intermediate; 
IV, protonated carbinolamine; IV, protonated carbinolamine; V, generated central 
complex E:NADH:α-kg:Lys; VI, products, α-kg and protonated lysine (13). 
 
1-5-5. Isotope effects 
 In the direction of saccharopine formation, finite primary deuterium kinetic 
isotope effects were observed for all parameters with the exception of V2/KNADH, which 
has a value of unity, indicating a steady state random addition of lysine and α-Kg with 
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NADH binding to free E.  DV2 and D(V2/KLys) are pH dependent and decrease towards 
unity at high pH, suggesting that, a step other than hydride transfer becomes rate-
limiting as the pH is increased. Data may indicate slow protonation/deprotonation of the 
carbinolamine nitrogen which is formed as an intermediate in imine hydrolysis. 
Finite solvent isotope effects suggest proton transfer also contributes to rate 
limitation. Multiple substrate/solvent isotope effects indicate a concerted hydride and 
proton transfer and also imply that proton transfer in another step, probably the 
hydrolysis of the imine. A dome-shaped proton inventory for both V2 and V2/KLys, is 
consistent with proton transfer in at least two sequential transition states. According to 
these studies, hydride transfer and the hydrolysis of imine are the rate limiting steps 
(83). 
 
1-5-7. Structures of SDH 
 Structures of saccharopine dehydrogenase from Saccharomyces cerevisiae, have 
been solved in the apoenzyme (1.64 Å) form (85), and in the presence of sulfate, 
adenosine monophosphate (AMP) and oxalylglycine (OG) (84). 
The apo-enzyme is composed of two similar sized domains, (domain I and II). 
Domain II is the dinucleotide binding domain, and contains a Rossmann fold (86), 
which binds NAD+ and NADH. Domain I consists of an α/β fold, which is similar to the 
dinucleotide binding domain in terms of general topology although it lacks the sequence 
homology. The active site of SDH is located within a deep cleft at the interface between 




Figure 1-4. The 1.64 Å structure of the apoenzyme form of saccharopine 
dehydrogenase from Saccharomyces cerevisiae shows the enzyme to be composed of 
two domains with similar dinucleotide binding folds with the active site locates in a 
deep cleft at the interface of two domains (85). 
 
 




Figure 1-5. A ribbon representation of the sulfate-bound saccharopine dehydrogenase 
from S. cerevisiae. The enzyme monomer shows three positions of bound sulfate 
molecules. Domain II contains a Rossmann fold (magenta) that binds dinucleotide 
substrates. There is a disulfide bond between Cys205 and Cys249, connecting the N-
terminal end of a helix to a loop that originates from the six-stranded β-sheet core. 






Figure 1-6. Comparative analysis of the apo (yellow) (85) and sulfate-bound (magenta) 
SDH molecules (84). (A) Surface representation of the apo form of SDH (84). (B) 
Binding of a sulfate molecule to Arg131, in the active site, induces an 11.8° rotation 
leading to 65% closure of the active site (84). (C) Close-up view of the active site area 
of the superimposed structures of apo (yellow) and sulfate-bound (magenta) SDH 
shows that the conformational change upon sulfate binding may be triggered by the 
movement of the Arg18, Lys77, and His96 side chains toward the negatively charged 
sulfate molecule. [reproduced with permission from Andi et. al, (2007) Biochemistry, 
46, 871-882] 
 
In the sulfate-bound structure (84), three sulfate ions are bound to one SDH 
molecule three positions, to SDH (Figures 1-5 and 1-6). One sulfate molecule binds to 
Arg131 which is located in the active site cleft. The other two sulfate molecules bind to 
arginine and lysine residues in solvent-exposed areas of domain I and II. 
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Sulfate binding to Arg131, mimics one of the carboxylates of α-Kg. Once 
sulfate is bound, a significant conformational change takes place, due to domain 
rotation of about 12° compared to the apoenzyme, resulting in a partial closure of the 
active site. By superposition of apo- and sulfate bound structures, Ala133-Ala134-
Phe135-Gly136, and Leu325-Pro326, with Gly136 and Pro326 were predicted to be the 
likely residues located in the hinge region. The mechanism of active site closure is not 
yet known. However, structural analysis reveals that the sulfate binding site is highly 
positively charged (Arg131, Lys77 and His96) and electrostatic interactions likely play 
a key role in the conformational change (84). 
 
1-5-7-2. AMP-bound structure 
AMP binds to the NAD+ subsite of the active site. The adenine, ribose and 
phosphate moieties of AMP interact with specific residues, of the protein (Figure 1-7), 
through eight hydrogen bonds and three hydrophobic interactions. The majority of 
binding energy of AMP is provided by the hydrogen bonding network (84)    
Kinetic data suggest that the AMP portion of NAD+ may bind first to the SDH 
active site. The ribose moiety of the AMP molecule forms two hydrogen bonds to 
Asp227, binding it tightly, in the active site, in agreement with the kinetic data. A 
conserved GXXGXXG motif, is 20 residues N-terminal to Asp227 suggesting that the 
Rossmann fold of SDH exhibits the characteristics of a classical NAD(P)+ binding 
domain (87, 88). Ki values obtained (74) for NAD+ and NADP+ are about the same, 
consistent with the fact that D227 can still form two hydrogen bonds to the ribose 
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moiety of NADP+, with the 2’-phosphate rotated away from the binding site. Structurally 
there is no steric hindrance for binding of the 2’-phosphate (84). 
 
                          
 
 
Figure 1-7. Structures of the active site of SDH with AMP-bound (84). (A) The 
phosphate moiety of the AMP interacts with the main chain of the enzyme. Direct 
interactionswith N atoms of Arg204 and Cys205 and indirect interactions with the O 
atoms of Gly200 and Cys249, through water molecules. (B)  The ribose moiety interacts 
directly with Asp227 and the main chain N atom of Gly203. Electron density of AMP is 
also shown. (C) Adenine interactions with Ile 199, Ile228, and Ile250 are hydrophorbic, 
but Thr231 donates a hydrogen bond to N1of adenine. [reproduced with permission 
from Andi et. al, (2007) Biochemistry, 46, 871-882] 
 
 pH dependence of the Ki  for AMP suggest the requirement for two functional 
groups required  for AMP binding, one protonated and the other unprotonated (74).  The 
crystal structure suggests that the unprotonated group is D227. However the nature of 
the protonated group is not known, and further studies are needed. Both apo- (84) and 
AMP bound enzyme forms were crystallized in the same space group, P212121, with 
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different cell dimensions, while both apo-SDH and OG-bound SDH were crystallized in 
the same space group (P212121), with the same cell dimensions (84). 
 
1-5-7-3. Oxalylglycine binding 
 
 
Figure 1-8. Stereoview of the oxalylglycine binding site in SDH. Arg18 and Arg131 
are involved in binding the two carboxylate groups of OG. Lys77 and His96 interact 
with the carbonyl oxygen of OG, and Lys77 is also within hydrogen bonding distance to 
the α-carboxylate. Phe135 and Ser323 interact indirectly via water molecules. 
[reproduced with permission from Andi et. al, (2007) Biochemistry, 46, 871-882] 
 
Oxalylglycine (OG) is a structural analog of α-Kg, hence its binding mimics α-
Kg binding to SDH (Figure 1-8).  The OG-bound crystal structure (84) shows that the 
α- and γ-carboxylates of OG interact with Arg18 and Arg131, respectively. This 
binding site can accommodate two to six carbon containing substrates, but according to 
kinetic data (74), five is the optimum number of carbon atoms that can be 
accommodated. Lys77 and His96 form hydrogen bonds of 2.81 Å and 3.03 Å, 
respectively with the α-keto group of OG. In SDH, the Rossmann fold domain is 
specific for binding dinucleotide substrates, while the other domain is specific for 
binding carboxylate-containing substrates or substrate analogues. The OG-binding 
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pocket in apo-SDH is occupied by a network of water molecules, bonded to Arg18 and 
Arg131 (84). 
 
1-5-7-4. Disulfide bridge(s) 
Cys205 and Cys249 reside on the surface of the nucleotide binding domain and 
are very close to the phosphate moiety of AMP. The location of these two cysteins 
make them vulnerable to oxidation, via disulfide bridge formation, as has been observed 
in both apo-, sulfate-bound and OG-bound structures (Figure 1-9). It has been proposed 
that the thiols act as a redox sensor responding to the environment of the cell during the 
cell cycle or to oxidative stress (84).  This aspect is under investigation (K. Bobyk, 
unpublished data in this lab). 
 
     
 
 
Figure 1-9. Cys205 and Cys249, which are involved in disulfide bond formation. (A) 
disulfide bond in the sulfate-bound SDH. (B) Reduced cysteines and their electron 
density in the AMP-bound structure[reproduced with permission from Andi et. al, 




1-5-8. Semiempirical model for substrate binding and chemical 
mechanism 
A semempirical model of the E·NAD+·saccharopine ternary complex has been 
developed (Figure 1-10) on the basis of the superposition of the experimentally 
determined crystal structures with AMP and OG bound (84). The proposed model is 
consistent with the previous kinetic data (51, 74, 81). It is semiempirical because the 
lysine portion of saccharopine and NMN+ portion of NAD+ are modeled. Also, the 
possible conformational changes, including the active site closure, as well as any 
synergetic interactions, due to binding of substrates to enzyme, were not considered 
when this model was proposed (84). 
 
Figure 1-10. Semiempirical model for the SDH·NAD+·saccharopine ternary complex. 
All of the interactions between enzyme residues and saccharopine are shown in dotted 
lines (average distance is 2.96 ± 0.18 Å). All of the residues are completely conserved 
and must be involved in the SDH reaction. In the model, saccharopine may form an 
intramolecular electrostatic bond, which folds the saccharopine onto itself to 
accommodate the substrate in the highly hydrophilic SDH active site and to minimize 




 According to the model, Lys99 and Glu122 make a network of electrostatic and 
hydrogen bonding interactions with the lysine moiety of saccharopine. Also the 
carboxylates of the glutamate moiety of saccharopine, are located in hydrogen bonding 
distance to Arg18 and Arg131. The secondary amine of saccharopine interacts directly 
with Lys77 and His96. There are intramolecular electrostatic interactions proposed 
within the saccharopine molecule and these interactions help to organize saccharopine 
and accommodate it in the binding pocket of SDH. The nicotinamide ring is well 
positioned so that it can accept a hydride from the pro-R face (75). In the semiempirical 
model, the distance between C4 of the nicotinamide ring of NAD+ and C4 of 
saccharopine is 4.7 Å, which is longer than the optimum distance for hydride transfer 
(2.6-3 Å). Thus, for catalysis to occur, a conformational change is required, as observed 
in the sulfate bound structure (84). 
 There are anumber of charged residues in the active site and many of them 
locate in average hydrogen bonding distance (2.99 Å) to the secondary amine of 
saccharopine, suggesting that they all are playing an important role(s) as 
catalytic/binding groups(s) and contribute to the overall SDH reaction. 
 
1-6. Studies in this Dissertation 
 This course of study is focused on the enzyme saccharopine dehydrogenase 
from Saccharomyces cerevisiae. The goal of this study was to obtain a detailed 
understanding of the overall significance of charged residues in the active site in order 
to establish a detailed mechanism for SDH. We hypothesized that as all charged 
residues are completely conserved across number of different organisms, they must 
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therefore play a significant role in contribution to the overall SDH reaction. To test our 
hypothesis, selected active site residues (E78, K99, E122, D319), were altered by site 
directed mutagenesis, either as single mutants or as double mutants. All mutant proteins 
were cloned, expressed, purified and characterized in detail and the data are presented 
and interpreted in this dissertation. 
 The ultimate goal, to which these studies make a significant contribution, is to 
expand our understanding of SDH on a global view, with respect to the function(s) of 
ionizable active site residues and their overall significance in the AAA pathway. In 
addition to that, although it is not the main focus or the primary goal of this project, the 
information and insight obtained from these detailed mechanistic studies, in the future 
may be useful for drug designers and developers, for designing effective 
inhibitors/antimicrobial agents against the pathogenic fungi utilizing the AAA pathway.  
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Glutamates 78 and 122, contribute to substrate binding and  
modulate the basicity of catalysts 
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2-1. Introduction 
The α-aminoadipate pathway (AAA1) for lysine biosynthesis is unique to fungi 
and euglenoids (1-3).  Lysine is an essential amino acid for most organisms.  Human 
pathogenic fungi including Candida albicans, Aspergillus fumigatus and Cryptococcus 
neoformans and the plant pathogen Magnaporthe grisea, use this pathway for lysine 
biosynthesis (4-6).  Knocking out the LYS1 gene is lethal to the fungal cells suggesting 
that selective inhibition of one or more enzymes, may help to control or completely 
eradicate these pathogens in vivo (5, 7).  
 
Scheme 2-1: SDH reaction.  
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Saccharopine dehydrogenase [SDH; N6-(glutaryl-2)-L-lysine: nicotinamide 
adenine dinucleotide (NAD+) oxidoreductase (L-lysine forming); (EC 1.5.1.7)] catalyses 
the final step of the α-aminoadipate pathway, the reversible pyridine nucleotide-
dependent oxidative deamination of saccharopine using NAD+ as the oxidizing agent, to 
produce α-ketoglutarate (α-Kg) and lysine (2) (Scheme 2-1).  SDH from S. cerevisiae is 
a monomer with a molecular weight of 41 kDa, with one active site (8). 
On the basis of the pH dependence of the kinetic parameters (9), dissociation 
constants for the competitive inhibitors (1) and isotope effects (9), a chemical 
mechanism has been proposed for SDH (1,10) (Scheme 2-2).  In the direction of 
saccharopine oxidation, once NAD and saccharopine are bound, a group with a pKa of 
6.2 accepts a proton from the secondary amine of saccharopine as it is oxidized.  The 
imine of saccharopine is hydrolyzed via general base catalyzed activation of a water 
molecule, and the intermediacy of carbinolamine intermediates.  The base participating 
in the hydrolysis reaction has a pKa of 7.2.  Finally, the ε-amine of lysine is protonated 
by the conjugate acid of the base with a pKa of 6.2, and products are released (1, 9, 10).  
Isotope effects suggest hydride transfer and hydrolysis of the imine contribute to rate 
limitation (9). 
Structures of SDH have been solved in the apo-enzyme form (11) and with 
either AMP or oxalylglycine (OG), analogues of NAD and α-Kg, bound (10). A semi-
empirical ternary complex structure of the E·NAD·saccharopine ternary complex was 
generated on the basis of E·AMP and E·OG structures, Figure 1 (10). Given the semi-
empirical nature of the model, the relative positions of reactants and active site groups 
are estimates, and the overall model represents an open form of the enzyme, e.g., the 
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distance for hydride transfer from the Cα proton of the glutamyl moiety to the 4 position 
of the nicotinamide ring is 4.7 Å, much too long for hydride transfer.  There are a 
number of ionizable residues in the active site, and a multiple sequence alignment of the 
SDH from Candida albicans, Pichia guilliermondii, Saccharomyces cerevisiae, 
Aspergillus fumigatus and Cryptococus neoformans indicated all are conserved in all 
five organisms, consistent with their importance in the mechanism. In the ternary 
complex R131 and R18 are likely ion-paired to two of the carboxylates of saccharopine. 
In addition, however, there are three lysine residues, K99 in the vicinity of the α- 
carboxylate of saccharopine, K77 in the vicinity of the secondary amine of 
saccharopine, and K13 near K77; three glutamates, E122 near K99, E78 near K77 and 
K13, and E16 near R18; and an imidazole, H96. 
In the ternary complex, the nicotinamide ring of NAD+ is positively charged, but 
in the vicinity of D319, and the secondary amine of saccharopine is positively charged 
given its pKa of about 10 (9).  The active site is positively charged, and this will 
certainly affect the pKa values of all of the ionizable residues in the site. 
In this manuscript the role of E78 and E122 was studied by changing them to 
glutamine or alanine.  Eliminating these negatively charged residues will increase 
positive charge in the site, and should affect the pKa values of the remaining residues, 
including the catalytic groups.  In addition, previous studies suggest there is a neutral 
acid in the vicinity of the secondary amine of saccharopine, and E78 and E122 are 
candidates for this residue (9).  Mutant enzymes were characterized via the pH 
dependence of kinetic parameters and isotope effects.  Data are discussed in terms of 









Scheme 2-2:  Chemical Mechanism Proposed for Saccharopine Dehydrogenase. 
Michaelis E·NAD+·saccharopine complex with NAD+ and saccharopine bound (I); 
imine intermediate (II); neutral carbinolamine intermediate (III); protonated 
carbinolamine intermediate (IV); protonated carbinolamine intermediate (V); product 
E·NADH·α-Kg·Lys complex with a neutral lysine ε-amine (VI); product E·NADH·α-








Figure 2-1.  Stereoview of the E•NAD+•saccharopine complex from a semi-empirical 
model (5).  The figure is obtained from the structures of SDH with sulfate bound 
(2QRJ), oxalylglycine bound (2QRL), and AMP bound (2QRK) from Saccharomyces 
cerevisiae (5).  The nicotinamide ring of NAD+ is shown to the left of the figure near 
Asp 319.  The figure was constructed using PyMol. 
 
 
2-2. Materials and methods 
2-2-1. Materials 
L-Saccharopine, L-lysine, α-ketoglutarate, ampicillin, chloramphenicol, 
phenylmethylsulfonyl fluoride (PMSF), horse liver alcohol dehydrogenase and baker’s 
yeast aldehyde dehydrogenase were obtained from Sigma.  β-NADH, β-NAD, 
Luria−Bertani (LB) broth, LB-agar and imidazole were purchased form USB.  Ches, 
Hepes, Mes, Taps, Tris, and imidazole were from Research Organics.  Ethanol-d6 (99% 
atom D) and D2O (99.9% atom D) were purchased from Cambridge Isotope 
Laboratories (CIL).  Ethyl alcohol (absolute, anhydrous) was from Pharmaco-Aaper.  
Isopropyl-β-D-1-thiogalactopyranoside (IPTG) was from Invitrogen and the GenElute 
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plasmid miniprep kit was from Sigma.  Ni−NTA agarose resin was from Qiagen.  The 
QuikChange site-directed mutagenesis kit was from Stratagene, and the plasmid 
purification kit was from Sigma. Bradford reagent (protein assay - dye reagent 
concentrate) was obtained from Bio-rad.  All chemicals were obtained commercially, 
were of the highest grade available, and were used without further purification. 
 
2-2-2. Site-directed mutagenesis  
Site-directed mutagenesis was performed using the plasmid sdhHX1, which 
contains the S. cerevisiae LYS1 gene (1), as a template in order to change E78 and E122 
to Q and A.  The forward and reverse primers used to generate the E78Q, E122Q, E78A 
and E122A are listed in the Table 2-1.  








aThe mutated codon is indicated in bold letters. 
 
Double mutant enzymes were prepared using the E78Q forward and reverse 
primers and the E122Q mutant gene to generate E78Q/E122Q, while E78A forward and 
reverse primers were used with the E122A mutant gene to generate E78A/E122A.  The 
PCR procedure was as follows.  The reaction mixtures were first heated to 94°C for 1 
Primersa DNA sequence from 5' to 3' 
E78Q - Forward AGAATCATTATAGGTTTGAAGCAATGCCTGAAACCGATACTTTC 
E78Q-Reverse GAAAGTATCGGTTTCAGGCATTGCTTCAAACCTATAATGATTCT 
E122Q- Forward CGGTACTCTATATGATTTGCAATTTTTGGAAAATGACC 
E122Q- Reverse GGTCATTTTCCAAAAATTGCAAATCATATAGAGTACCG 
78A-Forward CATTATAGGTTTGAAGCAAATGCCTGAAACCG 
E78A-Reverse CGGTTTCAGGCATTTGCTTCAAACCTATAATG 
E122A- Forward CACGGTACTCTATATGATTTGGCATTTTTGGAAAATGACCAAGGT 
E122A- Reverse ACCTTGGTCATTTTCCAAAAATGCCAAATCATATAGAGTACCGTG 
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minute to activate the Pfu-DNA polymerase Turbo enzyme.  Denaturation of double-
stranded plasmid DNA was done 94°C for 1.5 min.  Depending on the melting 
temperatures of the respective primers, annealing was set at 50-60°C for 2 minutes.  
Extension of the new DNA was carried out at 68°C for 8 minutes.  The cycle was 
repeated 18 times, and completion of existing transcripts was done at 68°C for 20 min.  
Original methylated plasmid was then digested using the DpnI restriction enzyme.  The 
presence of the new plasmid was estimated by agarose-gel electrophoresis, taking 
samples before and after addition of DpnI, from the PCR reaction mixture.  The XL-1-
Blue competent cell strain of Escherichia coli was then transformed with the plasmids 
containing mutations.  The transformed cells were grown overnight at 37°C in LB 
medium supplemented with ampicillin, 100 µg/mL.  Plasmids were isolated and 
purified using the GenElute plasmid miniprep kit.  The entire gene was then sequenced 
for all six mutations at the Sequencing Core of the Oklahoma Medical Research 
Foundation, Oklahoma City, OK. 
 
2-2-3. Expression and purification of mutant enzymes 
E. coli BL21 (DE3) RIL cells were transformed with plasmids containing the 
E78Q, E122Q, E78A, E122A, E78Q/E122Q or E78A/E122A mutant genes. All mutant 
proteins were expressed as previously described (1), using IPTG for induction.  Protein 
purification was also carried out as for wild type enzyme (1) with the exception that the 
imidazole concentration employed to elute the mutant protein depended on the mutant 
enzyme being purified.  Proteins bound to the Ni-NTA column were eluted using an 
imidazole gradient, 30-300 mM, at pH 8. The E78Q mutant enzyme eluted at 150-180 
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mM imidazole, while remaining mutant proteins eluted at 180-300 mM imidazole.  
Purity of the proteins was assessed using SDS−PAGE with the gel stained with 
Coomassie Brilliant Blue G-250. Protein concentration was measured by Bradford 
assay, by measuring the absorbance at 595 nm (11). 
 
2-2-4. Enzyme assay 
The SDH reaction was monitored via the appearance or disappearance of NADH 
at 340 nm (ε340 = 6220 M-1cm-1) using a Beckman DU 640 spectrophotometer.  All 
assays were carried out at 25 °C and the temperature was maintained using a Neslab 
RTE-111 water bath.  Rate measurements were carried out in 0.5 mL of 100 mM Hepes, 
pH 7.3.  Reactions were initiated by the addition of enzyme to a mixture containing all 
other reaction components, and the initial linear portion of the time course was used to 
calculate the initial velocity.  The amount of enzyme added was determined using an 
enzyme concentration series (v vs [E]) for each mutant enzyme. 
 
2-2-5. Initial velocity studies 
Initial velocity patterns were obtained for both the E78Q and E122Q mutant 
enzymes in both reaction directions, but only in the direction of saccharopine formation 
for the E78A, E122A, E78Q/E122Q and E78A/E122A mutant enzymes.  All data were 
collected at 25°C in 100 mM Hepes, pH 7.2.  In the direction of lysine formation, initial 
rates were measured for E78Q and E122Q mutant enzymes, as a function of 
saccharopine concentration (0.5-10 Km) at different fixed levels of NAD (0.5-10 Km).  In 
the direction of saccharopine formation, initial velocities for E78Q and E122Q were 
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measured as a function of lysine concentration (0.5-10 Km) at different fixed levels of α-
Kg (0.5-10 Km) with NADH maintained near saturation (≥ 10 Km).  Additionally, initial 
velocity studies were also carried out for wild type SDH as previously described (1).  
Lysine was added as the hydrochloride salt.  As a result of the high concentrations of 
lysine used, as high as 1.2 M, the effect of added NaCl on the initial rate was tested; no 
effect was found. 
 
2-2-6. Pairwise analysis 
Pairwise analyses were performed for E78A, E122A E78Q/E122Q and 
E78A/E122A, as previously described (1), in the direction of saccharopine formation.  
One substrate was varied (0.5-10 Km) at different fixed concentrations of the second one 
(0.5-10 Km) maintaining the third substrate near saturation (≥ 10 Km).  This experiment 
was carried out for all reactant pairs: Lys/α-Kg, NADH/α-Kg and NADH/Lys. 
 
2-2-7. Dead-end inhibition studies 
Inhibition patterns were measured for all mutant proteins at the extremes of pH 
(6 and 9) using oxalylglycine (OG), a structural analog of α-Kg, as the dead end 
inhibitor.  Lysine was varied at different fixed concentrations of OG including zero, 
while NADH and α-Kg were maintained at saturation and at a low concentration (2Km), 
respectively.  In order to determine whether there was a change in the kinetic 
mechanism, a dead-end inhibition pattern was also obtained for the E78A/E122A 
mutant protein at pH 7.2.  The initial rate was measured at different fixed levels of 
NADH (around Ki NADH), varying OG (0.5-5 Ki), with lysine and α-Kg maintained at 
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2Km.  A pattern was also obtained by varying Lys (0.5-10 Km), at different fixed levels 
of OG, at fixed α-Kg (1.5 Km) and with NADH near saturation (10 Km).  The appKi for 
OG in all cases was first estimated by measuring the rate as a function of OG with other 
reactants fixed at Km, plotting 1/v versus I, and extrapolating 1/v to zero. 
 
2-2-8. pH studies 
In order to determine whether the mutations affected the pKa values observed in 
the pH-rate profile of the wild type SDH, initial velocity was measured in the direction 
of saccharopine formation as a function of pH at 25 °C.  The pH dependence of V, the 
V/KLys and V/Kα-Kg was measured as a function of pH (5-10).  The V/K values were 
obtained by measuring the initial rate as a function of one substrate with all others 
maintained at saturation.  Experiments were carried out for only the single mutant 
proteins, varying α-Kg with the other two substrates fixed at saturation (≥10 Km).  For 
both double mutant enzymes, lysine inhibited the reaction at low concentrations of α-
Kg, and thus V/Kα-Kg was not determined.  The pH was maintained using the same 
buffers over the same pH range, as before (1).  No buffer effects were observed on any 
mutant enzyme.  The pH was recorded before and immediately after measuring the 
initial velocity at 25 °C; no significant differences were detected. 
 
2-2-9. Isotope effects 
2-2-9-1. Primary substrate deuterium kinetic isotope effects 
Isotope effects were measured for all mutant enzymes in the pH independent 
region of their pH-rate profiles, (pH 5 for E78A, pH 9.5 for E78Q, E122Q, E122A and 
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E78A/E122A and pH 7.2 for E78Q/E122Q).  Effects were measured in the direction of 
saccharopine formation, using NADD as the deuterated substrate (1).  DV2 and 
D(V2/KLys) were obtained for all mutant proteins, by measuring the initial rates in 
triplicate, as a function of lysine concentration (0.5-10 Km), at saturating levels of α-Kg 
(10 Km) and NADH(D) (10 Km). 
4R-4-2H NADH and NADD were prepared as previously described (13).  
Briefly, ethanol-d6 (or ethanol) and NAD were incubated with alcohol and aldehyde 
dehydrogenases in 6 mM Taps, pH 9, at room temperature, for 1-2 hours.  The pH was 
maintained at pH 9 using 0.1 N KOH throughout the reaction time course.  After 2 
hours, the reaction was quenched by vortexing with a few drops of CCl4, and the 
aqueous layer was separated.  The purity of the final NADH(D) was estimated by 
measuring the absorbance ratio at 260/340 nm; a ratio of 2.27 ± 0.06 was obtained 
similar to the value of 2.15 ± 0.05 pure compound (10).  The concentrations of 
NADH(D) was estimated using a ε340 of 6220 M-1cm-1.  The initial rates measured using 
the same concentrations of commercial NADH and the NADH prepared as above, were 
similar.  The NADH(D), was used immediately after preparation without further 
purification. 
 
2-2-9-2. Solvent deuterium kinetic isotope effects.  
The isotope effects were obtained by direct comparison of initial rates, in 
triplicate, in D2O and H2O, in the pH(D) independent region of the pH-rate profiles 
(14).  For rates measured in D2O, substrate preparation and pH(D) adjustments were 
done as previously described (1).  Initial rates were measured varying lysine at fixed 
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saturating levels of NADH and α-Kg (≥10 Km).  Reactions were initiated by adding a 
small amount of each of the mutant enzymes in H2O. 
 
2-2-9-3. Multiple solvent deuterium/substrate deuterium kinetic isotope effects.   
Multiple isotope effects were determined in the direction of saccharopine  
formation, for all mutant enzymes, by direct comparison of the initial rates in H2O and 
D2O as above, varying lysine at a fixed saturating concentration of NADD and α-Kg 
(≥10 Km). 
 
2-2-10. Data analysis 
Initial rate data were first analyzed graphically, using double-reciprocal plots of 
initial velocities versus substrate concentrations and suitable secondary and tertiary 
plots, to determine the quality of the data and the proper rate equation for data fitting.  
Data were then fitted using the appropriate equations according to Cleland (15) and the 
Marquardt-Levenberg algorithm (16), supplied with the EnzFitter program from 
BIOSOFT, Cambridge, U.K.  Kinetic parameters and their corresponding standard 
errors were estimated using a simple weighting method.  Data obtained from the initial 
velocity patterns, in the absence of added products, were fitted using either eq.1 for a 
sequential mechanism, or eq. 2 with the constant term absent, or eq. 3 for competitive 
inhibition by B, in a sequential mechanism.  Data obtained from dead end inhibition 
patterns were fitted using eqs.4 and 5 for competitive and parabolic competitive 
inhibition by oxalylglycine, respectively. Noncompetitive (NC) and uncompetitive (UC) 
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In equations 1-7, v and V are initial and maximum velocities, A, B and I are 
substrate and inhibitor concentrations, Ka and Kb are Michaelis constants for substrates 
A and B respectively.  In eqs. 1 and 3, Kia is the dissociation constant for A from the EA 
complex and KIB is the substrate inhibition constant for B.  In eqs. 4-7, Kis and Kii are 
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the slope and intercept inhibition constants, respectively. Parabolic competitive 
inhibition requires two molecules of I to bind in sequence to E. Kis1 and Kis2 are the 
inhibition constants for E·I and E·I2 complexes, respectively. 
Data for pH-rate profiles that decreased with a slope of 1 at low pH and a slope 
of -1 at high pH were fitted using eq 8.  Data for pH rate profiles with a slope of +1 at 
low pH were fitted using eq. 9, while data for pH-rate profiles with a slope of -1 at high 
pH were fitted using eq. 10.  Data for the E78A V2/Et pH-rate profile were fitted to eq. 
11.  Data for pH-rate profiles with a slope of +1 at low pH and a partial change at high 
pH were fitted using eq. 12.  Similarly, data for pH rate profiles with a slope of -1 at 
high pH and a partial change at low pH were fitted using eq. 13.  Data for pH-rate 
profiles with limiting slopes of +1 and -1 at low and high pH respectively, and with a 
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In eqs. 8-14, y is the observed value of the parameter (V or V/K) at any pH, C is 
the pH independent value of y, H is hydrogen ion concentration, K1, K2 and K3 represent 
acid dissociation constants for enzyme or substrate functional groups, YL and YH are 
constant values of V or V/K at the low and high pH, respectively. 
Isotope effect data were fitted using eqs. 15 and 16, which allows the isotope 
effects on V and V/K to be independent or equal, respectively. 
 
















In eq. 15 and 16, Fi is the fraction of deuterium label in the substrate or D2O in 
the solvent, EV/K and EV are the isotope effects minus 1 on V/K and V, respectively, and 
Ev is the isotope effect minus 1 on V and V/K, when they are equal to one another.  All 
other parameters are as defined above. 
Molecular graphics. The active site figure of SDH was prepared using 
PyMOLTM version 0.99 (17). 
 
2-3. Results 
2-3-1. Cell growth, protein expression, and purification 
Expression of the E78Q, E122Q, E78Q/E122Q, E78A, E122A, and 
E78A/E122A mutant enzymes was nearly three times lower than that of the WT SDH 
using the same conditions employed for WT.  The E78Q mutant enzyme was eluted 
from the Ni-NTA column with buffer containing 150-180 mM imidazole at pH 8, while 
all others eluted at >180 mM imidazole.  Purity of the proteins was assessed using 
SDS−PAGE and all the mutant proteins were estimated to be >98% pure.  The amount 
of purified enzyme obtained from a 1 L culture, for E78Q, E122Q, E78A, E122A, 
E78Q/E122Q and E78A/E122A was 1, 0.7, 4, 3, 2.7 and 3.7 mg, respectively.  His-
tagged mutant SDH proteins are active and stable for months when kept at 4 °C in 100 
mM Tris and 300 mM KCl at pH 8. 
 
2-3-2. Initial velocity studies of E78Q, E122Q and E78Q/E122Q  
Double reciprocal initial velocity patterns were obtained at pH 7, in both 
reaction directions, for the E78Q and E122Q mutant enzymes as discussed in methods.  
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However, the cost of saccharopine prohibited measuring initial rate data for all of the 
mutant enzymes in the direction of Lys formation, and data were obtained only in the 
direction of saccharopine formation for the remaining mutant enzymes.  Initial velocity 
patterns intersect to the left of the 1/v axis (data not shown), consistent with the 
sequential mechanism proposed for the WT enzyme.  For the E78Q/E122Q mutant 
enzyme, NADH/Lys pair exhibited a parallel double reciprocal plot while the Lys/α-Kg 
pair illustrated inhibition by lysine at low α-Kg levels.  The Michaelis constants for Lys 
and α-Kg increased 25- and 18-fold, respectively for E78Q/E122Q.  V2/KLysEt 
decreased about 60-fold for E122Q, while the V/K values for lysine and α-Kg decreased 
at least 22- fold for E78Q/E122Q.  Kinetic parameters are summarized in Table 2-2. 
 
2-3-3. Pairwise analysis 
Initial velocity patterns for E78A, in the direction of saccharopine formation, for all 
three variable pairs, Lys/α-Kg, α-Kg/NADH and NADH/Lys are similar to WT (1).  
Patterns intersect to the left of the ordinate for Lys/α-Kg pair, while the α-Kg/NADH 
and the NADH/Lys gave a series of parallel lines (data not shown).  For E122A, the 
double reciprocal plot for the Lys/α-Kg pair, exhibited a parallel pattern (data not 
shown).  Inhibition by α-Kg, and lysine is observed at low NADH concentrations, for α-
Kg/NADH (data not shown), and the NADH/Lys pairs, respectively.  The pattern, 
exhibiting competitive substrate inhibition by Lys for NADH/Lys pair is shown in 
Figure 2 (A) as an example.  For E78A/E122A, the double reciprocal plot for α- 
Kg/NADH, differed from that of the WT and exhibits a pattern that intersects to the left 
of the ordinate, Figure 2 (B), suggesting there might be a change in kinetic mechanism.  
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The Lys/α-Kg and NADH/Lys pairs, exhibited inhibition by lysine, at low 
concentrations of α-Kg or NADH, respectively.  For the E122A and E78A/E122A 
mutant enzymes, KLys increased more than 30- and 170- fold respectively, while Kα-Kg 
increased 40- fold for E78A/E122A.  The V/K for lysine decreased for E122A and 
E78A/E122A by more than 45- and 190- fold, respectively, and the V/K for α-Kg 
decreased 55- fold for E78A/E122A.  However, kcat did not show significant changes, 
compared to WT, for any of the mutant enzymes.  Plots are not shown but the kinetic 
parameters obtained at pH 7.3 and 25° C for all mutant proteins are summarized in 
Tables 2-2 and 2-3. 
 
2-3-4. Dead-end inhibition studies 
Dead end inhibition data were obtained for all mutant proteins.  With the 
exception of E78A, noncompetitive inhibition by OG against lysine was observed at pH 
6 and 9. On the other hand, E78A gave competitive inhibition by OG against lysine.  At 
pH 9, linear competitive inhibition was observed, while parabolic competitive inhibition 
by was observed at pH 6, Figure 3.  Data are summarized in Table 4. 
In order to determine whether the kinetic mechanism of the E78A/E122A 
mutant enzyme remains the same as WT, inhibition by OG vs. NADH was obtained at 
pH 7.2.  For E78A/E122A, at pH 7.2, OG was an uncompetitive inhibitor vs. NADH 
with a Kii of 0.50 ± 0.03 mM, while it was noncompetitive against lysine, with Kis and 
Kii values of 0.70 ± 0.05 and 1.40 ± 0.06 mM, respectively, suggesting binding of OG 




              
 
Figure 2-2: Initial Velocity Patterns for the E122A and E78A/E122A Mutant Enzymes.  
A. Double reciprocal plot of initial rate (E122A) as a function of the concentration of 
NADH, as shown at different fixed levels of lysine: 20 mM (♦); 29.4 mM (▲); 52.6 
mM (■); and 300 mM (●).  The concentration of α-Kg was fixed at 5 mM (saturation).  
Data exhibit competitive substrate inhibition by lysine.  The points are experimental, 
while the lines are based on a fit to eq. 3.  B.  Double reciprocal plot of initial rate 
(E78A/E122A), as a function of the concentration of α-Kg as shown at different fixed 
levels of NADH: 0.025 mM (♦); 0.036 mM (▲); 0.068 mM (■) and 0.54 mM (●). The 
concentration of Lys was fixed at 1200 mM (saturation).  The points are experimental, 





                     
Figure 2-3: Parabolic Competitive Inhibition by Oxalylglycine against Lysine for 
E78A.  Double reciprocal plot of initial rate as a function of lysine concentration as 
shown at different fixed levels of OG: 0 mM (■); 0.01 mM (●); 0.05 mM (▲); 0.1 mM 
(♦).  The concentrations of NADH and α-Kg were fixed at 0.4 mM (saturation) and 0.4 
mM (2 Km) respectively.  The points are experimental, while the lines are theoretical on 
the basis of a fit to eq. 5.  The inset shows a plot of slope vs. OG, illustrating the 
parabolic slope effect.  The curve is determined using eq. 5. 
 
 
2-3-5. pH studies  
The pH dependence of kinetic parameters was determined, for all of the mutant 
enzymes, in the direction of saccharopine formation, at 25 °C.  Results are shown in 
Figures 2-4 to 9.  All mutant enzymes were active and stable over the pH range 5-10.  
pKa values and pH independent values of parameters are summarized in Table 5. V2/Et 
of E78Q, E122A and E78A/E122A is independent of pH over the range used. V2/KLysEt 
is bell-shaped for E122Q, E78A and E122A as for WT, but the pKas of the groups 
involved in binding and or catalysis have been shifted to lower and higher pH compared 
to WT.  The exception is E122A, which exhibits a partial change on the acid side. 
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Table 2-2. Kinetic parameters for the E78Q, E122Q and E78Q/E122Q. 
 
Kinetic parameters 










V1/Et (s-1) 1.1 ± 0.1 3.95 ± 0.01 0.76 ± 0.04 ND 
Fold change  + 3.6 -1.45  
V1/KNADEt (M-1s-1) (1.2±0.1)×103 (3.62±0.58)×103 (2.31±0.3)×102 ND 
Fold change  + 3.1 -5.2  
V1/KSacEt (M-1s-1) (1.6±0.3)×102 (2.1±0.4)×103 (5.5±0.3)×101 ND 
Fold change  +13 -3 ND 
KSac (mM) 6.7 ± 1.4 2.0 ± 0.4 14.0 ± 0.8 ND 
Fold change  -3.4 +2.1  
KNAD (mM) 0.9 ± 0.1 1.1 ± 0.2 3.3 ± 0.4 ND 
Fold change  +1.2 +3.7  
KiNAD (mM) 1.1 ± 0.3 0.5 ± 0.3 1.9 ± 0.3 ND 
Fold change  -2.0 +1.7 ND 
Reverse reaction 
V2/Et (s-1) 20.0 ± 1.0 11.2 ± 0.4 4.3 ± 0.1 24.7 ± 2.6 
Fold change  -1.2 -4.6 +1.2 
V2/KNADHEt (M-1s-1) (1.6±0.2)×106 (8.0 ± 0.3)×105 (1.9 ± 0.2)×105 (2.0±0.2)×105 
Fold change  -2 -8.4 -8 
V2/KLysEt (M-1s-1) (2.5±0.4)×104 (2.8 ± 0.2)×103 (4.100±0.001)×102 (9.1±0.9)×102 
Fold change  -8.8 -60.7 -27.4 
V2/Kα-Kg Et (M-1s-1) (2.8 ± 0.7)×105 (4.9 ± 0.3)×104 (1.50 ± 0.07)×104 (1.3±0.1)×104 
Fold change  -5.7 -18 -22 
KNADH (mM) 0.019 ± 0.002 0.014 ± 0.004 0.025 ± 0.002 0.12 ± 0.01 
Fold change  -1.4 +1.3 +6.3 
KLys (mM) 1.1 ± 0.2 4.0 ± 0.4 11.0 ± 0.6 27.1 ± 1.3 
Fold change  +3.6 +10 +24.5 
Kα-Kg  (mM) 0.11 ± 0.03 0.23 ± 0.02 0.30 ± 0.01 2.0 ± 0.5 
Fold Change  +2.1 +2.7 +17.8 
 
 
Kinetic parameters were determined in both reaction directions for E78Q and 
E122Q. For E78Q/E122Q mutant enzyme it was determined only in the direction 
of saccharopine formation.  The reactions were monitored at 25°C and at pH 7.2. 





 Table 2-3. Kinetic parameters for E78A, E122A and E78A/E122A mutant enzymes. 
Kinetic parameters 









V2/Et (s-1) 20.0 ± 1.0 88.8 ± 4.7 19.4 ± 0.8 24.80 ± 0.04 
Fold change  +4.4 ~1 +1.2 
V2/KNADHEt (M-1s-1) (1.6 ± 0.2)×106 (2.5 ± 0.1)×106 (3.1±0.1)×105 (2.20 ± 0.03)×105 
Fold change  +1.53 -5.1 -7.3 
V2/KLysEt (M-1s-1) (2.5 ± 0.4)×104 (1.43 ± 0.08)×105 (5.3 ± 0.2)×102 (1.300±0.002)×102
Fold change  +5.7 -47 -192 
V2/Kα-Kg Et (M-1s-1) (2.8 ± 0.7)×105 (4.9 ± 0.4)×105 (3.5 ± 0.2)×104 (5.11 ± 0.01)×103 
Fold change  +1.8 -8 -55 
KNADH (mM) 0.019 ± 0.002 0.036 ± 0.003 0.062 ± 0.034 0.113 ± 0.001 
Fold change  +1.9 +3.3 +5.9 
KLys (mM) 1.1 ± 0.2 0.62 ± 0.01 36.5 ± 1.1 190.7 ±1.4 
Fold change  -1.76 +33.0 +176 
Kα-Kg (mM) 0.11 ± 0.03 0.180 ± 0.002 0.556 ± 0.004 4.850 ± 0.001 
Fold change  +1.6 +5.1 +44.1 
KiNADH (mM) 0.017 ± 0.003 0.038 ± 0.001 0.019 ± 0.003 0.015 ± 0.002 
Fold change  +2.2 N/A N/A 
 
             Kinetic parameters for E78A, E122A and E78A/E122A mutant enzymes, in the direction of saccharopineformation  
   at 25° and pH 7.2. Wild type data (1), are included for comparative purposes. N/A is not applicable.
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pH Kis (mM) Kii (mM) pattern 
6 0.06 ± 0.01 0.12 ± 0.03 NC E78Q 
9 0.48 ± 0.09 0.6 ± 0.10 NC 
6 0.056 ± 0.010 0.28 ± 0.07 NC E122Q 
9 0.26 ± 0.07 0.13 ± 0.01 NC 
6 0.53 ± 0.08 1.52 ± 0.2 NC E78Q/E122Q 
9 0.47 ± 0.08 0.27 ± 0.06 NC 
6 Kis1 = 0.030±0.008 
Kis2 = 0.005 ± 0.003 
- C-Parabolic  
E78A 
9 0.40 ± 0.01 - C 
6 0.07 ± 0.01 0.28 ± 0.07 NC E122A 
9 1.08 ± 0.22 0.24 ± 0.02 NC 
6 0.71 ± 0.10 1.88 ± 0.6 NC E78A/E122A 
9 1.60 ± 0.08 2.03 ± 0.06 NC 
On the acid side of the E78Q V2/KLysEt pH-rate profile, the pKa of the group observed for 
the WT enzyme is absent. V2/KαKgEt pH-rate profiles for E122Q and E122A are bell-
shaped, giving a pKa on the acid side of the profile, not observed for WT. 
 
2-3-6. Substrate deuterium kinetic isotope effects.   
Primary deuterium kinetic isotope effects were measured by direct comparison 
of initial rates as a function of Lys concentrations at pH 7.2 for E78A, E78Q and 
E122Q; at pH 5 and 9 for E78A, and at pH 7.0 for E78A/E122A and E78Q/E122Q. 
Experiments were carried out at 25 °C, using A-side NADD as the labeled substrate. 
With one exception, mutant enzymes exhibited finite isotope effects on both V and V/K.  
The exception is E78A, which gave a D(V) of 0.9 ± 0.1.  Given isotope effects larger 
than WT, hydride transfer appears to contribute to rate limitation somewhat more for 
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the E78A/122A, E122A and E122Q mutant enzymes.  Data obtained for all mutant 
enzymes are summarized in Tables 2-6 and 2-7. 
 
2-3-7. Solvent deuterium kinetic isotope effects. 
Isotope effects were measured by direct comparison of the initial rates as a 
function of Lys concentration in H2O and D2O in the pH(D) independent range of the V 
and V/K pH-rate profiles.  For E78A, solvent isotope effects could only be measured at 
pH 9; different α-Kg concentrations were required in D2O and H2O. E78Q, E122A, 
E122Q, E78Q/E122Q and E78A/E122A had solvent isotope effects similar to those of 
WT, while E78A had relatively small but significant solvent isotope effects.  Data are 
summarized in Tables 2-6 and 2-7. 
 
2-3-8. Multiple solvent deuterium/substrate kinetic deuterium isotope 
effects. 
Multiple isotope effects were measured in H2O and D2O using NADD as the  
dinucleotide substrate in order to examine whether the substrate and solvent isotope 
effects reflect the same or different steps. E78A/E122A exhibited the largest multiple 
isotope effect, about 3.5, on V and V/K.  E78A also exhibited larger multiple isotope 
effects, about 2.7, relative to a value of about 1.6 for WT.  Data obtained for all mutant 







  Table 2- 5: Summary of data obtained from pH rate profiles. 




V = (5.8 ± 0.3)x101 
pK1= 5.8 
pK2 = 8.4 
 
V/K = (1.44 ± 0.07)×105 
(pK1+pK2)/2 = 7.2 
 
V/K= (2.16 ± 0.08)×105 
pK2= 8.9 
E78Q V = (2.00 ± 0.05) V/K=(5.2 ± 0.2)×103 
pK2 = 8.45 ± 0.03 
V/K=(9.92 ± 0.15)×104 




V = 5.09 ± 0.03 
pK1=5.90 ± 0.03 
V/K = (5.05 ± 0.07)×102 
pK1= 6.50 ± 0.04 
pK2= 8.80 ± 0.05 
V/K = (1.9 ± 0.4)×104 
pK1 = 6.30 ± 0.04 





VH = 20.9 ± 0.5 
VL = 5.24 ± 0.33 
pK2= ( 8.20 ± 0.07)* 
V/KH= 75.6 ± 5.3 
V/KL = 29.2 ± 1.6 
V/KL0 = 2.06 ± 0.60 
pK1= 6.05 ± 0.07* 
pK2 = 8.01 ± 0.14 






VH =(1.5 ± 0.1)×102 
VL= 11.6 ± 0.6 
pK1= 6.8 ± 0.06 
V/K = (1.8 ± 0.1)×105 
pK1= 6.1 ± 0.1 
pK2= 8.5 ± 0.1 
V/K = (4.2 ± 0.3)×105 




V =14.12 ± 0.14 
V/KH = (4.9 ± 0.2)×102 
V/KL = (2.8 ± 0.4)×101 
pK1= (6.98 ± 0.06)* 
pK2=8.7 ± 0.1 
V/K =(1.96 ± 0.23)×104 
pK1=6.3 ± 0.12 




V = 22.4 ± 0.2 
 
V/K H = (2.19 ± 0.03)×102 
V/K L= (2.7 ± 0.1)×101 
pK1= 6.66 ± 0.03* 
pK2= 8.4 ± 0.1  
 
ND 
V and V/K represent the pH independent values in the respective profile; VH and V/KH represent highest pH independent value, VL and V/KL represent 
the lower pH independent value and VL0 and V/KL0 represent the lowest pH independent values, for the respective pH profile.  Units of V and V/K are s-1 
and M-1 s-1, respectively.  pK1 indicates the pKa of the group involved in the acid side of the profile where as pK2 and pK3 indicate the pKas of the groups 
involved, in the base side of the profiles.  (*) mark indicates the groups which were important but not essential for catalysis/binding. Wild type data are 





Figure 2-4: pH dependence of kinetic parameters for the SDH E78Q mutant enzyme in 
the direction of saccharopine formation.  Data were obtained at 25 oC for V2/Et (D), 
V2/KLysEt (E) and V2/Kα-KgEt (F).  Data for WT SDH are included for comparison [V2/Et 
(A), V2/KLysEt (B) and V2/KαKgEt (C)] (12).  The points are the experimentally 
determined values, while the curves are theoretical based on fits of the data using eq. 7 




On the basis of the semi-empirical model of the E·NAD·saccharopine ternary 
complex of the S. cerevisiae SDH (10), there are a number of ionizable residues in the 
active site, as discussed in the Introduction.  Although all cannot participate in general 
base catalysis, they are all completely conserved in all of the enzymes for which 







Figure 2-5.  pH dependence of kinetic parameters for the SDH E78A mutant enzyme in 
the direction of saccharopine formation.  Data were obtained at 25 oC for V2/Et (A), 
V2/KLysEt (B) and V2/Kα-KgEt (C).  The points are the experimentally determined values, 









































Figure 2-6.  pH dependence of kinetic parameters for the SDH E122Q mutant enzyme 
in the direction of saccharopine formation.  Data were obtained at 25oC for V2/Et (A), 
V2/KLysEt  (B) and V2/KαKgEt (C).  The points are the experimentally determined values, 
while the curves are theoretical based on fits of the data using eq. 9 for A, and eq. 8 for 




           
  
 
Figure 2-7.  pH dependence of kinetic parameters for the SDH E122A mutant enzyme 
in the direction of saccharopine formation.  Data were obtained at 25oC for V2/Et (A), 
V2/KLysEt (B) and V2/KαKgEt (C).  The points are the experimentally determined values, 
while the curves are theoretical based on fits of the data using eq. 8 for C.  The curve 








Figure 2-8. pH dependence of kinetic parameters for the SDH E78Q/E122Q mutant 
enzyme in the direction of saccharopine formation.  Data were obtained at 25oC for 
V2/Et (A), and V2/KLysEt (B).  The points are the experimentally determined values, 




long-term goal is to obtain an estimate of the contribution of each of the residues in the 
active site to reactant binding and catalysis, directly or indirectly.  This will require 
estimates of the reactant Kd values, microscopic rate constants for the catalytic steps, 
and pH-rate profiles to show whether the residues changed have an effect on pKa 
values.  In this manuscript we have looked at the effect of E78 and E122 on the overall  
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reaction.  Elimination of either or both of the glutamate side chains increases positive 
charge in the site, and the effect of mutating these side chains is discussed below. With 
the exception of the E78Q and E122Q mutant enzymes, all other mutant enzymes were 






Figure 2-9.  pH dependence of kinetic parameters for the SDH E78A/E122A mutant 
enzyme in the direction of saccharopine formation.  Data were obtained at 25oC for 
V2/Et (A), and V2/KLysEt (B).  The points are the experimentally determined values, 






 Table 2 6.  Isotope effects data obtained for the E78Q, E122Q and E78Q/E122Q. 
Parameter Wild type SDH E78Q E122Q E78Q/E122Q 
 
D(V) 1.50 ± 0.07 1.48 ± 0.04 1.60 ± 0.01 1.30 ± 0.03 
D(V/KLys) 1.60 ± 0.05 1.48 ± 0.04 2.30 ± 0.04 1.30 ± 0.03 
 
D2O(V) 2.2 ± 0.1 2.5 ± 0.1 1.96 ± 0.04 2.01 ± 0.06 
D2O(V/KLys) 1.9 ± 0.1 2.5 ± 0.1 1.96 ± 0.04 2.01 ± 0.06 
 
D2O(V)D 1.76 ± 0.08 
(80% D2O) 
 
2.40 ± 0.04 1.60 ± 0.01 1.200 ± 0.001 
D2O(V/KLys)D 1.86 ± 0.08 
(80% D2O) 
 
1.60 ± 0.03 1.60 ± 0.01 1.400 ± 0.003 
 
All isotope effects were measured in the direction of saccharopine formation.  
Lysine was varied while maintaining NADH and α-Kg at saturation (>10 Km), at 
25°C.  Data were measured at the following pH values:  7.2 for E78Q and E122Q 
and 7 for E78Q/E122Q.  Wild type data are included for comparative purposes. 
 
 
2-4-1. Kinetic mechanism 
The kinetic mechanism of SDH from S. cerevisiae is ordered in the direction of 
lysine formation with NAD bound before saccharopine, while in the reverse reaction 
direction NADH binds to E, but lysine and α-Kg bind in random order (1).  In addition, 
above pH 8 the mechanism in the reverse reaction direction changes to ordered with α-
Kg binding after NADH and before lysine (9).  With the exception of E78A mutant 
enzyme, data indicate the kinetic mechanism of all mutant enzymes is the same as WT. 
In agreement, OG dead-end inhibition patterns at pH 6 and 9 are noncompetitive against 
lysine, for all mutant enzymes with the exception of E78A.  The largest changes in Kis 
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Table 2-7. Isotope effects for the E78A, E122A and E78A/E122A mutant enzymes. 
Parameter Wildtype SDH E78A E122A E78A/E122A
 
D(V) 1.50 ± 0.07 (pH 5) 
0.9 ± 0.1 
 (pH 9) 
1.13 ± 0.03 
2.1 ± 0.1 2.24 ± 0.10 
D(V/KLys) 1.60 ± 0.05 (pH 5) 
1.9 ± 0.1 
 (pH 9) 
1.13 ± 0.03 
1.5 ± 0.1 2.24 ± 0.10 
 
D2O(V) 2.2 ± 0.1 (pH 9) 
1.43 ± 0.05 
1.8 ± 0.1 2.40 ± 0.05 
D2O(V/KLys) 1.9 ± 0.1 (pH 9) 
1.43 ± 0.05 
2.6 ± 0.2 2.40 ± 0.05 
 
D2O(V)D 1.76 ± 0.08 
(80% D2O) 
(pH 5) 
2.90 ± 0.02 
 (pH 9) 
1.20 ± 0.01 
2.10 ± 0.04 3.6 ± 0.1 
D2O(V/KLys)D 1.86 ± 0.08 
(80% D2O) 
(pH 5) 
2.90 ± 0.02 
 (pH 9) 
1.20 ± 0.01 
2.50 ± 0.08 
 
 





and Kii for OG are observed for the double mutant enzymes, E78Q/E122Q and 
E78A/E122A, and the E122A single mutant enzyme. The NC inhibition by OG vs. α-
Kg is indicative of binding of OG to E·NADH and E·NADH·Lys complexes. The 
increase in the values of Kis and Kii is consistent with the observed decrease in affinity 
for α-Kg to the mutant enzymes, compared to the WT. Data are consistent with the 
change in kinetic parameters, Tables 2 and 3. Most changes are small, but those for 
V/KLys are the largest for E122Q, E122A, and the double mutants E78Q/E122Q and 
E78A/E122A; changes in V are small (<5-fold), but high values for KLys were observed, 
suggesting E122 contributes to lysine binding. 
However, in the case of E78A, at both pH 6 and 9, OG exhibits competitive 
inhibition, indicating that OG competes with Lys and binds to the same binding site as 
Lys. OG is somewhat structurally similar to Lys, so the subtle changes occurring in the 
active site due to mutagenesis likely permit this.  At pH 6, E78A exhibits parabolic 
competitive inhibition indicating OG binds to both E·NADH and E·NADH·OG 
complexes.  The dissociation constants for OG suggest that binding OG to E·NADH 
makes it much more favorable for binding the second OG. 
At pH 7, for E78A/E122A, UC dead-end inhibition by OG vs NADH indicates 
that α-Kg binds after NADH is bound to the enzyme, while NC inhibition from OG vs 
Lys suggests binding of α-Kg to both E.NADH and E·NADH·Lys complexes.  The 
kinetic mechanism of this enzyme at pH 7 remains the same as that of WT.  The 
intersecting pattern observed in the initial velocity pattern when α-Kg and NADH are 




2-4-2. Isotope effect data 
The kinetic mechanism of SDH in the direction of saccharopine formation at  
neutral pH can be written as shown in mechanism17. In  mechanism 17, A, B, C, P and 
Q represent NADH, α-Kg, Lys, saccharopine and NAD.  The rate constants k1 and k2 
are for binding and dissociation of NADH. k3, k4, k7 and k8 are for binding and 
dissociation of α-Kg, and k5, k6 k9 and k10 are for binding and dissociation of lysine, k11 
and k12 are the forward and reverse net rate constants for the catalytic pathway while k13 





Mechanism 17:  Kinetic Mechanism Proposed for Saccharopine Dehydrogenase from 
Saccharomyces cerevisiae. 
 
The substrate deuterium sensitive step, hydride transfer, contained in k11, the net 
rate constant for catalysis, may exhibit an isotope effect upon deuteration of NADH at 
the C-4 pro-R hydrogen of the dihydronicotinamide ring if the transition state for 
reduction of the imine (II in Scheme 2-2) contributes to rate limitation.  The solvent 
isotope effect reflects protons in flight in the transition state for formation of the iminie 
(II in Scheme 2-2) from the carbinolamine (III in Scheme 2-2) and to a lesser extent, 
proton transfer in the transition state for the hydride transfer step (1). 
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All of the mutant enzymes exhibited finite substrate deuterium isotope effects on 
V and V/K.  In addition, all values are similar to those of WT. Data suggest hydride 
transfer contributes to rate limitation of the SDH reaction.  The value of D(V) for the 
E122A and E78A/E122A mutant enzymes is greater than that of WT, as is D(V/K) for 
E78A/E122A, suggesting E122 is catalytically important but not essential. 
In the case of the Q mutant enzymes, the isotope effects are very similar to those 
of WT, Table 6.  Data suggest only minor changes in the relative rates of steps along the 
reaction pathway result from the E78Q and E122Q single mutations, or from the 
E78Q/E122Q double mutation.  Thus the glutamine side chain can effectively replace 
the glutamate side chain at neutral pH, i.e., the negative charge is not critical to the 
overall reaction.  However, when E78 and E122 are changed to A, the isotope effects 
differ from those of WT.  For the E78A mutant enzyme, the first and second order rate 
constants, V and V/K, are slightly higher than WT at high pH, while the isotope effects 
are close to unity for primary substrate deuterium, solvent and multiple kinetic isotope 
effects at high pH.  Thus, it appears that steps other than chemistry limit this mutant 
enzyme.  (The low pH effect will be discussed below when pH-rate profiles are 
considered).   
In the case of E122A and E78A/E122A mutant enzymes, results are similar, 
isotope effects are either the same as those of WT or higher.  Overall data suggest the 
chemical steps contribute more to rate limitation, and this is especially true in the case 
of the E78A/E122A double mutant, where the multiple isotope effect is the largest 
observed for SDH thus far.  Of the two residues considered, E122 appears to be 
important for the overall integrity of the catalytic machinery, although it is almost 
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certainly not a catalytic group given the small changes in V/Et observed.  In order to 
obtain quantitative estimates of the contribution of the two residues to catalysis, 
estimates of microscopic rate constants must be obtained.  Although obtaining these 
estimates are planned, they require extensive multiple isotope effects including primary 
15N, and α- and β-secondary isotope effects, and these studies are beyond the scope of 
this manuscript.  Enough information is provided for the reader to know that the plan of 
procedure, although labor intensive, will ultimately provide a comprehensive and 
quantitative description of how the enzyme’s active site catalyzes the oxidative 
deamination reaction. 
 
2-4-3. Lysine binding 
The kinetic parameter most affected by mutation of E78 and E122 is V/KLys, and 
as a result KLys.  The dissociation constants for Lys from the E·NADH·α-Kg·Lys 
complex can be calculated from the isotope effects according to Klinman and Matthews 
(18); [DV-1]/[D(V/K)-1] = Km/Kd.  If the isotope effects are equal to one another, Km = 
Kd, while if they are not, Kd can be estimated from the remaining known values.  Kd 
values estimated in this way are given in Table 2-8. 
From the dissociation constants in Table 8, the contribution of E78 and E122 to 
lysine binding can be calculated, and a thermodynamic cycle can be constructed to 
show the interaction between the two residues (19). The free energy of binding lysine to 
the E•NADH•α-Kg complex is calculated from ∆Go = −RTln 1/Kd( ), and the change 
resulting from the mutation is estimated from the expression 
( ) ( )[ ]WTdtmudo KKG /1ln1/lnRT tan −=∆∆ . The free energy of binding lysine to the 
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E•NADH•α-Kg complex is calculated from ∆Go = −RTln 1/Kd( ), and the change 
resulting from the mutation is estimated from the expression 










EEWT GGGGG 781221221227878122/78 −−−−− ∆∆+∆∆=∆∆+∆∆=∆∆ , where 
o
EEWTG 122/78−∆∆  is the total change from WT to double mutant enzyme independent of 
whether E78 or E122 is changed first, o EWTG 78−∆∆  and 
o
EWTG 122−∆∆  are the changes 
resulting from the single mutations, while ∆∆GE 78−E122
o  and ∆∆GE122−E 78
o  are the changes 
from the single to the double mutant enzymes.  If there is a synergistic interaction 
between the two residues, 
[ ]oGoGGG EWTEWTo EEWTocoupling 12278122/78 −−− ∆∆+∆∆−∆∆=∆∆  where 
∆∆Gcoupling
o  is the interaction energy between E78 and E122.  
Table 2-8:  Calculated Kd values for Lysine.a 
Enzyme Kd (mM) 
WT-SDH 1.32 ± 0.17 
E78Q 4.0 ± 0.4 
E122Q 23.85 ± 1.53 
E78Q/E122Q 27.1 ± 1.3 
E78A 0.62 ± 0.01 
E122A 16.5 ± 2.3 
E78A/E122A 190.7 ± 1.1 
       




Thermodynamic cycles for the Q and A mutant enzymes, respectively, are shown in 


















and thus E78 and E122 cooperate in the binding of lysine.  The difference in the 
coupling free energies for Q and A mutations, suggests the effect includes contributions 
from charge (2.4 kJ/mol) and other (including dipolar and perhaps steric) interactions 
(5.5 kJ/mol).  The charge effect is expected given the negatively charged glutamate side 
chains and the positively charged α- and ε-amines of lysine (lysine is net positively 
charged as it binds to enzyme).  The E78A mutant enzyme has a slightly lower Kd 
compared to the WT, indicative of a slightly tighter binding of lysine, perhaps because 
of a better accommodation of the lysine side chain.  However, the effect is small (0.4 
kcal/mol), and does not affect the interpretation of the role of E78.  The larger effect of 
replacing the side chain suggests changes to the overall site, including an increase in 
volume, and perhaps an increase in proximity of like-charged residues; there are a 
number of lysines in the site, Figure 1-1. 
 
2-4-4. pH-rate profiles 
As suggested above and in mechanism 17, SDH exhibits random addition of 































Scheme 2-3:  Thermodynamic Analysis of Lysine Binding in E78 and E122 Glutamine 
and Alanine Mutant Enzymes.  Binding free energies and estimated ∆∆Go values for 
lysine binding in the: A. E78Q, E122Q, and E78Q/E122Q mutant enzymes, and B. 
E78A, E122A, and E78A/E122A mutant enzymes. ∆Go values were calculated using 
the dissociation constant for lysine from the E·NADH·α-Kg·Lys complex, and ∆∆Go 




ordered with α-Kg binding prior to lysine (1).  The V/KLys pH-rate profile exhibits 
groups in the E·NADH·α-Kg complex and free lysine over the entire pH range, while 
V/Kα-Kg exhibits groups in the E·NADH·lysine complex and free α-Kg from pH 5-8.5 
and the E·NADH complex and free α-Kg outside this pH range.  The V pH-rate profile 
exhibits groups on enzyme in central complexes (chemical steps contribute to rate 
limitation (9)) over the pH range 5-8.5. 
Changes in kinetic parameters and isotope effects are not consistent with a direct 
catalytic role for E78 and E122.  The pH-rate profiles provide the best evidence for how 
the glutamate side chains function in the reaction.  The E78Q and E78A mutant 
enzymes exhibit a V/Kα-Kg pH-rate profile that is nearly identical to that of WT, 
suggesting that there is no effect on the rate processes in the pathway where α-Kg binds 
to the E·NADH·lysine complex, including all steps to release of the saccharopine 
product.  There are changes in V at pH values <6, specifically, the group with a pKa of 
about 6 is not observed for either E78Q or E78A, and in addition, the partial change 
observed at high pH is suppressed in the E78Q mutant enzyme.  The biggest change, 
however, is in the V/KLys.  The pKa values observed for the WT enzyme, an average of 
7.2 (9), and reflecting enzyme side chains in the E·NADH·Kg complex, are perturbed to 
lower and higher pH in the E78Q and E78A mutant enzymes.  On average, they are 
perturbed by ~1.5 pH units in E78Q and by ~1.2 in E78A.  Data suggest both glutamate 
side chains contribute to setting the pKa values of the catalytic groups near neutrality, 
likely a result of their effective charge and/or direct interaction with the catalytic 
group(s).  The active site of SDH is net neutral when NADH and α-Kg are bound, given 
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an equal number of lysine and glutamate residues and H96, which is likely neutral, 
Figure 1-1. 
The changes observed when E122 is mutated are similar in some respects and 
differ in others.  The V pH-rate profile for E78A is missing the partial change at high 
pH that was indicative of a change in kinetic mechanism from random addition of lysine 
and α-Kg at neutral pH to ordered addition of α-Kg prior to lysine at high pH.  Data 
suggest the kinetic mechanism is random over the entire pH range.  In agreement, the 
E122Q and E122A pH-rate profiles for V/Kα-Kg and V/KLys both exhibit pKa values for 
the acid and base catalysts as is true for the WT V/KLys pH-rate profile.  However, as is 
true for the E78Q and E78A mutant enzymes, the pKa values are perturbed outward.  
The group with the base side pKa in the V/KLys pH-rate profile is more sensitive to the 
substitution at E122, and is perturbed ~1.6 pH units higher, while that on the acid side is 
decreased by slightly less than 1 pH unit.  In addition, the decrease in the V/KLys pH-rate 
profile appears to be partial at low pH, and this may indicate the influence of one of the 
other active site residues on binding of lysine.  As for the Q mutant enzymes the 
explanation is likely similar, with E122 closer to one of the catalytic residues than the 
other.  It is tempting to say the residue that is closest to E122 is H96, but the ternary 
complex pictured in Figure 1-1 is semi-empirical, and this aspect will have to await 
future studies. 
The pH-rate profiles for the double mutant enzymes appear to be a sum of those 
of the single mutant enzymes.  However, they are weighted toward the effect of 





Considering all of the data, E78 and E122 do not play a direct role in catalysis, 
but their presence provides a modulation of the basicity of the catalytic groups in the 
active site of SDH, i.e., the pK values of the acid-base catalysts are tuned to a pH near 
neutrality.  Additional residues in the active site are now being considered to further 
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K99 and D319 bind substrates and contribute to hydrogen bonding 
network in the active site. 
 
3-1. Introduction 
Saccharopine dehydrogenase catalyzes the final step of α-aminoadipate pathway 
(AAA1) for lysine biosynthesis; a unique pathway to fungi and euglenoids (1-3).  Lysine 
is an essential amino acid for mammals.  Human pathogenic fungi, including Candida 
albicans, Cryptococcus neoformans and Aspergillus fumigatus and the plant pathogen 
Magnaporthe grisea, use this pathway for lysine biosynthesis (1, 2, 4).  Knocking out 
the LYS1 gene is lethal to fungal cells, suggesting that selective inhibition of one or 
more enzymes, may help to control or completely eradicate these pathogens in vivo (4, 
5). Therefore, the enzymes of this pathway provide potential tools for designing 
effective antimycotic drugs. 
Saccharopine dehydrogenase [SDH; N6-(glutaryl-2)-L-lysine: nicotinamide 
adenine dinucleotide (NAD) oxidoreductase (L-lysine forming);(EC 1.5.1.7)] catalyses 
the reversible pyridine nucleotide-dependent oxidative deamination of saccharopine 
using NAD as the oxidizing agent, to produce lysine and α–ketoglutarate (α-Kg), 
Scheme 1 (6).  SDH from S. cerevisiae is a monomer with a molecular weight of 41 












Scheme 3-1. Reaction catalyzed by SDH in the physiological reaction direction. 
 
Structures of SDH have been solved in the apo-enzyme form (8) and with either 
AMP or oxalylglycine (OG), analogues of NAD+ and α-Kg, bound (9).  A semi-
empirical ternary complex structure of the E·NAD+·saccharopine ternary complex was 
generated on the basis of E·AMP and E·OG structures, Figure 3-1 (9).  Given the semi-
empirical nature of the model, the relative positions of reactants and active site groups 
are estimates, and the overall model represents an open form of the enzyme, e.g., the 
distance for hydride transfer from the Cα proton of the glutamyl moiety to the 4 position 
of the nicotinamide ring is 4.7 Å, much too long. There are a number of ionizable 
residues in the active site, and a multiple sequence alignment of the SDH from 
Saccharomyces cerevisiae, Candida albicans, Pichia guilliermondii, Aspergillus 
fumigatus and Cryptococus neoformans indicated all are conserved in all five 
organisms, consistent with their importance in the mechanism.  In the ternary complex 




addition, however, there are three lysine residues, K99 in the vicinity of the α-
carboxylate of saccharopine, K77 in the vicinity of the secondary amine of 
saccharopine, and K13 near K77; three glutamates, E122 near K99, E78 near K77 and 
K13, and E16 near R18; and an imidazole, H96. All of these are completely conserved. 
In the ternary complex, the nicotinamide ring of NAD+ is positively charged, but in the 
vicinity of D319, and the secondary amine of saccharopine is positively charged given 
its pKa of about 10 (10).  The active site is positively charged, and this will certainly 




Figure 3-1. Semi-empirical model for E•NAD+•saccharopine complex (9) (reproduced 
with permission).  The figure is obtained from the structures of SDH with sulfate bound 
(2QRJ), oxalylglycine bound (2QRL), and AMP bound (2QRK) from Saccharomyces 
cerevisiae (9). The nicotinamide ring of NAD+ is shown making hydrogen bonding 
interactions with Asp319. Lys99 make hydrogen bonding interactions with Lysine 
moiety of the saccharopine, and E122. The figure was constructed using PyMol (14)..  





 In this manuscript the roles of K99 and D319 were studied by changing them to 
methionine and alanine, respectively. On the basis of the proposed semi-empirical 
model, eliminating the charges on these residues is expected to disturb the fine balance 
of the hydrogen bonding network, disrupting the integrity of the active site, and giving 
effects on the binding of substrates, and the pKa values of the active site residues, 
including the catalytic groups. Mutant enzymes were prepared in the C205S 
background, which eliminates disulfide formation, so that 100% of the enzyme is in the 
“reduced” active form. Both enzymes were completely characterized via the pH 
dependence of kinetic parameters and isotope effects.  Data are discussed in terms of 
the proposed mechanism of SDH. 
 
3-2. Materials and methods 
 
3-2-1. Materials  
Ches, Hepes, Mes, Taps, Tris, and imidazole were from Research Organics.   β-
NADH, β-NAD, Luria−Bertani (LB) broth, LB-agar and imidazole were purchased 
form USB. L-Saccharopine, L-lysine, α-ketoglutarate, ampicilin, chloroamphenicol, 
phenylmethylsulfonyl fluoride (PMSF), baker’s yeast alcohol dehydrogenase and 
aldehyde dehydrogenase were obtained from Sigma  Ethanol-d6 (99% atom D) and D2O 
(99.9% atom D) were purchased from Cambridge Isotope Laboratories (CIL).  Ethyl 
alcohol (absolute, anhydrous) was from Pharmaco-Aaper.  Isopropyl-β-D-1-
thiogalactopyranoside (IPTG) and the Gen-elute plasmid miniprep kit were from 
Invitrogen.  Oxalylglycine was from Echelon. Ni−NTA agarose resin was from Qiagen.  




purification kit was from Invitrogen.  All chemicals were obtained commercially, were 
of the highest grade available, and were used without further purification. 
 
3-2-2. Site-directed mutagenesis  
 Site-directed mutagenesis was performed using the plasmid carrying the C205S 
mutation of the LYS1 gene (3) from S. cerevisiae  in order to change K99 and D319 to 
M and A, respectively. The C205S mutant enzyme is used as the background in place of 
wild type, since it cannot be oxidized, oxidation affects V and V/KNADH at low pH1.  The 
forward and reverse primers used to generate the K99M and D319A are listed in the 
Table 3-1 and the PCR procedure was as follows.  The reaction mixtures were first 
heated to 94°C for 1 minute to activate the Pfu-DNA polymerase Turbo enzyme.  
Denaturation of double-stranded plasmid DNA was done at 94°C for 1.5 min.  
Annealing took place at 50°C for 2 minutes for both K99M and D319A.  Extension of 
the new DNA was carried out at 68°C for 18 minutes.  The cycle was repeated 18 times, 
and elongation and completion of the reaction was done at 68°C for 20 min.  The 
original methylated plasmid DNA was then digested using the Dpn1 restriction enzyme.  
The presence of the new plasmid was estimated by agarose-gel electrophoresis, taking 
samples before and after addition of Dpn1, from the PCR reaction mixture.  The XL-1-
Blue competent cell strain of Escherichia coli was then transformed with the mutant 
plasmids.  The transformed cells were grown overnight at 37°C in LB medium 
supplemented with ampicillin, 100 µg/mL.  Plasmids were isolated and purified using 
the Gen-elute plasmid miniprep kit.  The entire gene was then sequenced for each 
mutant gene at the Laboratory for gene sequencing of the Oklahoma Medical Research 




Table 3-1: DNA sequence for the forward and reverse PCR primers. 








Names of the mutated plasmids are on the left column and “F” and “R” stand for 
forward and reverse direction respectively. Primers are aligned 5׳ to 3׳ from left to 
right. aThe mutated codon is indicated in bold letters. 
 
3-2-3. Expression and purification of mutant enzymes  
  E. coli BL21 (DE3) RIL cells were transformed with plasmids containing the 
K99M and D319A mutant genes.  All mutant proteins were expressed as previously 
described (3), using IPTG for induction.  Proteins bound to the Ni-NTA column were 
eluted using 300 mM imidazole at pH 8.  Proteins were dialyzed against 100 mM Tris-
HCl, 300 mM KCl at pH 8 at 4 °C, for 2-6 hours. Purity of the proteins was assessed 
using SDS−PAGE as previously described (3), and the protein concentration was 
measured by using Bradford reagent, measuring the absorbance at  595 nm with BAS as 
the standard (15). 
 
3-2-4. Enzyme assay 
The SDH reaction was monitored via the disappearance of NADH at 340 nm 
(ε340 = 6220 M-1cm-1) or at 370 nm (where the NADH extinction coefficient is half), 




the temperature was maintained using a Neslab RTE-111 water bath.  Rate 
measurements were carried out in 0.5 mL of 100 mM Hepes, pH 7.2. Reactions were 
initiated by the addition of enzyme to a mixture containing all other reaction 
components, and the initial linear portion of the time course was used to calculate the 
initial velocity.  The amount of enzyme added was determined using an enzyme 
concentration series (v vs [E]) for each mutant enzyme. 
 
3-2-5. Initial velocity studies 
 Initial velocity patterns were obtained for the K99M and D319A mutant 
enzymes in the direction of saccharopine formation. All data were collected at 25°C in 
100 mM Hepes, pH 7.2. Initial velocities for were measured as a function of lysine 
concentration (0.5-10 Km) at different fixed levels of α-Kg (0.5-10 Km) with NADH 
maintained near saturation (≥ 5 Km).  Initial velocity studies were also carried out 
varying lysine concentration (0.5-10 Km) at different fixed levels of NADH (0.5-10 Km) 
with α-Kg maintained near saturation (≥ 10 Km). Salt effects were determined using 
NaCl/KCl up to 1.3 M, but none were observed. 
 
3-2-6. Dead-end inhibition studies   
Inhibition patterns were measured for the D319A mutant enzyme at pH 6 using 
oxalylglycine (OG), a structural analog of α-Kg, as a dead-end inhibitor.  NADH was 
varied at different fixed concentrations of OG (0, 3, 6, and 9 mM) , while Lys and  α-Kg 




via Dixon plot (1/v vs [OG]), with the rate measured as a function of OG, while 
maintaining all three substrates at 1.5 Km.  
 
3-2-7. pH studies   
In order to determine whether the mutations affected the pKa values observed in 
the pH-rate profiles of the wild type SDH, the initial velocity was measured in the 
direction of saccharopine formation as a function of pH at 25°C. For the D319A mutant 
enzyme, the pH dependence of V and the V/K was measured by varying lysine as a 
function of pH (5-10), maintaining α-Kg and NADH at saturation. The experiment was 
repeated for NADH, at fixed saturating concentrations of Lys and α-Kg. However, for 
K99M, the app Km values obtained for Lys and NADH, at pH 6 and 9 were too high so 
that saturation levels could not be achieved for the two substrates; therefore, activities 
were measured in the pH range of 6 to 9. The pH was maintained using the following 
buffers at 100 mM concentration: Mes 5.3-6.8; Hepes, 6.8-8.2; Ches; 8.2-10.3. 
Sufficient overlap was obtained upon changing buffers to eliminate buffer effects. No 
buffer effects were observed.  The pH was recorded immediately after measuring the 
initial velocity at 25°C. 
 
3-2-8. Isotope effects  
3-2-8-1. Primary substrate deuterium kinetic isotope effects  
Isotope effects were measured for the D319A mutant enzyme, in the pH 
independent region(s) of its pH-rate profile, pH 5.5 and 9. For K99M, substrate 




the direction of saccharopine formation, using NADD as the deuterated substrate (3).  
DV2 and D(V2/KLys) were obtained for both mutant proteins, by measuring the initial rates 
in triplicate, as a function of lysine concentration (0.5-5 Km), at saturating levels of α-
Kg (10 Km) and NADH(D) (10 Km). 
4-R-4-2H NADH and NADH were prepared as previously described (10).  
Briefly, ethanol-d6 (or ethanol) and NAD+ were incubated with alcohol and aldehyde 
dehydrogenases in 6 mM Taps, pH 9, at room temperature, for 1-2 hours. After 2 hours, 
the reaction was quenched by vortexing with a 1 ml of CCl4, several times, and the 
aqueous layer was separated.  The purity of the final NADH(D) was estimated by 
measuring the absorbance ratio at 260/340 nm; a ratio of 2.27 ± 0.06 was obtained 
similar to the value of 2.15 ± 0.05 expected for pure compound (10).  The concentration 
of NADH(D) was estimated using a ε340 of 6220 M-1cm-1.  The initial rates measured 
using the same concentrations of commercial NADH and the NADH prepared as above 
were similar.  The NADH(D) was used immediately after preparation without further 
purification. 
 
3-2-8-2. Solvent deuterium kinetic isotope effects 
  The isotope effects were obtained by direct comparison of initial rates, in 
triplicate, in H2O and D2O, at pH 7 for K99M and D319A in the pH(D) independent 
region of the pH-rate profiles. Initial rates were measured varying lysine at fixed 
saturating levels of NADH and α-Kg (≥10Km).  Reactions were initiated by adding a 
small amount of each of the mutant enzymes in H2O. For rates measured in D2O, 




of D2O and lyophilized overnight to remove exchangeable protons. The lyophilized 
powders were then dissolved in D2O to give the desired concentrations, and the pD was 
adjusted using either DCl or NaOD. A value of 0.4 was added to pH meter readings to 
calculate pD (13).  
 
3-2-8-3. Multiple solvent deuterium/substrate deuterium kinetic isotope effects 
 Multiple isotope effects were determined in the direction of saccharopine 
formation by direct comparison of the initial rates in H2O and D2O as above, at pH 7, 
varying lysine at a fixed saturating concentration of NADD and α-Kg (≥10Km). 
 
3-2-9. Data analysis  
 Initial rate data were first analyzed graphically using double-reciprocal plots of 
initial velocity versus substrate concentration. Double reciprocal plots, suitable 
secondary and tertiary plots were visually evaluated to determine the quality of the data 
and the proper rate equations for data fitting. All plots were linear and the data were 
fitted using the appropriate rate equations and programs developed by Cleland (12) and 
the Marquardt-Levenberg algorithm, supplied with the EnzFitter program (16) from 
BIOSOFT, Cambridge, U.K.  Kinetic parameters and their corresponding standard 
errors were estimated using a simple weighting method.  Data obtained from the initial 
velocity patterns, in the absence of added products, were fitted using either eq.1 for a 
sequential mechanism, eq. 2 with the constant term absent, or eq. 3 for competitive 
inhibition by B, in a sequential mechanism.  Data obtained from dead-end inhibition 
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v = VA
Ka + A 1+ I Kii( )
                                                                                        (4) 
In equations 1-4, v and V are initial and maximum velocities, A, B and I are 
substrate and inhibitor concentrations, and Ka and Kb are Michaelis constants for 
substrates A and B, respectively.  In eqs. 1 and 3, Kia is the dissociation constant for A 
from the EA complex and KIB is the substrate inhibition constant for B.  In eq. 4, Kii is 
the intercept inhibition constant. Data for pH-rate profiles that decreased with a slope of 
1 at low pH and a slope of -1 at high pH were fitted using eq 5.  Data for the D319A 
V2/Et pH-rate profile were fitted to eq. 6, while data for pH-rate profile with a slope of -





















Cy                                                                         (5) 
  
log y = log
YL K1 H( )+ YH



























              In eqs. 5-7, y is the observed value of the parameter (V or V/K) at any pH, C is 
the pH independent value of y, H is hydrogen ion concentration, K1, and K2 represent 
acid dissociation constants for enzyme or substrate functional groups, YL and YH are 
constant values of V or V/K at the low and high pH, respectively.  
Isotope effect data were fitted using eqs. 8 and 9, which allows the isotope 
effects on V and V/K to be independent or equal, respectively. 











A                                                                                      (9) 
In eq. 8 and 9, Fi is the fraction of deuterium label in the substrate or D2O in the 
solvent, EV/K and EV are the isotope effects minus 1 on V/K and V, respectively, and E 
is the isotope effect minus 1 on V and V/K, when they are equal to one another.  All 
other parameters are as defined above. 
Molecular graphics.  The active site figure of SDH was prepared using 
PyMOLTM version 0.99 (14). 
 
3-3. Results 
3-3-1. Cell growth, protein expression, and purification   
Expression of the C205S/K99M and C205S/D319A mutant enzyme was nearly 
two times lower than that of the WT SDH using the same conditions employed for WT.  
All mutant proteins were eluted from the Ni-NTA column with buffer containing 300 
mM imidazole at pH 8.  Purity of the proteins was assessed using SDS−PAGE as 




purified enzyme obtained from a 1 L culture for K99M and D319A mutant proteins was 
2.53 and 2.0 mg, respectively.  His-tagged mutant SDH proteins are active and stable 
for nearly 5-6 months when kept at 4°C in 100 mM Tris and 300 mM KCl at pH 8. 
 
3-3-2. Initial velocity studies of the K99M and D319A mutant enzymes  
Double reciprocal initial velocity patterns were obtained at pH 7.2 in the 
direction of saccharopine formation. For the K99M mutant enzyme, Lys/NADH pair 
exhibited competitive substrate inhibition by high concentrations of Lys at low NADH 
levels (Figure 3-2 A). The patterns obtained varying Lys at different fixed 
concentrations of α-Kg, intersected to the left of the ordinate (Figure 3-2 B for K99M), 
consistent with the sequential mechanism proposed for the WT enzyme. The double 
reciprocal plot obtained from varying α-Kg at different fixed levels of NADH, exhibited 
lines intersected to the left of the ordinate (Figure 3-2 C). The initial velocity pattern 
obtained from D319A, varying NADH and α-Kg at fixed saturating concentrations of 
Lys, exhibited parallel lines (data not shown). 
The Michaelis constants for KLys, KNADH and Kα-Kg for K99M increased 903-, 20- 
and 10- fold, respectively. V2/KLysEt decreased about 175- fold while the V/K values for 
α-Kg and NADH decreased at least 125- and 34- fold respectively.  For D319A, KNADH 
increased 23 fold and V/KNADH decreased 72 fold, respectively. The substrate inhibition 
constants (KiB) of Lys for K99M was 1140 ± 160 mM, while the substrate inhibition 
constant for α-Kg for D319A was 4.0 ± 0.5 mM. Kinetic parameters obtained for both 












Figure 3-2.  Initial Velocity Pattern for the K99M Mutant Enzyme. (A). Double 
reciprocal plot of initial rate as a function of the concentration of NADH, as shown at 
different fixed levels of lysine: 10 mM (♦); 13.3 mM (▲); 19.8 mM (●); 39 mM (♦) and 
1.2 M (◙).  The concentration of α-Kg was fixed at 100 mM (saturation).  Data exhibit 
competitive substrate inhibition by lysine.  The points are experimental, while the lines 
are based on a fit to eq 3. (B).  Double reciprocal plot of initial rate as a function of the 
concentration of Lys, shown at different fixed levels of α-Kg, 2.5 mM (♦); 3.7 mM (▲); 
7.14 mM (■) and 100 mM (●). The concentration of NADH was fixed at 1.5 mM 
(saturation).  The points are experimental, while the lines are based on a fit to eq. 1.  
(C). Double reciprocal plot of initial rate as a function of the concentration of α-Kg, 
shown at different fixed levels of NADH, 0.008 mM (♦); 0.01 mM (▲); 0.024 mM (■) 
and 1.2 mM (●). The concentration of Lys was fixed at 1.2 M (saturation).  The points 
are experimental, while the lines are based on a fit to eq. 1.  
 
3-3-3. Dead-end inhibition studies 
  The double reciprocal plot obtained for D319A varying NADH at different 
fixed levels of OG, as a structural analog of α-Kg, at pH 7 exhibited parallel lines, 
suggesting uncompetitive dead-end inhibition by OG against NADH. The intercept  




Table 3-2: Kinetic parameters for C205S, K99M and D319A mutant enzymes.  
 
Kinetic parameters 
at pH 7.2 
C205S K99M D319A 
V2/Et (s-1) (1.06 ± 0.02)×102 68 ± 1 35.4 ± 0.5 





 (3.25 ± 0.05)×10
5 (1.54 ± 0.05)×105 
Fold change  -34 -72 
V2/KLysEt (M-1s-1) (1.2 ± 0.1)×10
5
 (6.8 ± 0.3)×10
2 (2.91± 0.04)×104 
Fold change  - 175 - 4.12 
V2/Kα-Kg Et (M-1s-1) (9.7 ± 0.6)×10
5
 (7.8 ± 0.1)×10
3 (1.70 ± 0.02)×105 
Fold change  -125 -3.3 
KNADH (mM) 0.010 ± 0.002 0.20 ± 0.01 0.23 ± 0.01 
Fold change  + 20 + 23 
KLys (mM) 0.11 ± 0.01 99 ± 4 1.2 ± 0.2 
Fold change  +902 + 11 
Kα-Kg (mM) 0.9 ± 0.1 8.8 ± 0.4 0.21 ± 0.02 
Fold change  +10 -4.2 
 
As stated in methods, the C205S mutant enzyme is the reference for all mutant studies. 
It is also concluded that all mutant enzymes adds in to the C205S mutation. Data were 
obtained in the direction of saccharopine formation at 25°C and pH 7.2 and C205S data 
(K. Bobyk, unpublished data from this lab), are included for comparative purposes. 
 
3-3-4. pH studies 
 The pH dependence of kinetic parameters was determined for D319A in the 
direction of saccharopine formation at 25°C.  Results are shown in Figures 3-3 (A-C). 




pH independent value of (132 ± 8) s-1 to a lower pH independent value of (12.6 ± 0.1) s-
1.  The pKa of the group indicated in the D319 profile is about 6.8. 
 
 
Figure 3-3: pH Dependence of Kinetic Parameters for the D319A Mutant Enzyme in 
the Direction of Saccharopine Formation.  Data were obtained at 25oC for V2/Et (A), 
V2/KLysEt (B) and V2/Kα-KgEt (C).  Data for the C205S mutant enzyme are included for 
comparison [V2/Et (D), V2/KLysEt (E) and V2/KαKgEt (F)] (K. Bobyk, unpublished data).  
The points are the experimentally determined values, while the curves are theoretical 
based on fits of the data using eq. 5 for B, C and F, eq. 6 for A and D, eq. 7 for E. 
 
 
V2/KNADHEt for D319A decreases at low and high pH with limiting slopes of +1 
and -1, giving pKa of 5.9 ± 0.1 and 9.1 ± 0.1. V2/KNADHEt was 9.0 ± 0.7 × 105 M-1 s-1. 
The V2/KLys for D319A also decrease at low and high pH giving pKas of 6.3 ± 0.2 and 




order rate constant, the pH independent value of V2/KLysEt was 3.2 ± 0.6 × 104 M-1 s-1. 
The pH dependence of the kinetic parameters for K99M could not be measured due to 
very high substrate concentration required for pH values below or above pH 7.0. 
 
3-3-5. Isotope effects 
3-3-5-1. Substrate deuterium kinetic isotope effects  
Primary deuterium kinetic isotope effects were measured by direct comparison 
of initialrates as a function of Lys concentrations at pH 7.3 for K99M and at pH 9 for 
D319A. Both mutant proteins exhibited finite effects. The data are summarized in Table 
3-3. 
3-3-5-2. Solvent kinetic deuterium isotope effects   
Isotope effects were measured by direct comparison of the initial rates as a 
function of Lys concentration in H2O and D2O in the pH(D) independent range of the V 
and V/K pH-rate profiles.  Solvent isotope effects for both mutant enzymes were 
measured at pH 7.0.  Solvent isotope effect data are summarized in Table 3-3. 
 
3-3-5-3. Multiple solvent deuterium/substrate kinetic deuterium isotope effects 
  Multiple isotope effects were measured in H2O and D2O using NADD as the 
dinucleotide substrate in order to examine whether the substrate and solvent isotope 






Table 3-3. Summary of the isotope effects for K99M and D319A. 
 
Kinetic parameters C205S K99M D319A 
 
D(V) (pH9) 
1.3 ± 0.2 
(pH7) 
2.22 ± 0.03 
(pH 9) 
1.13 ± 0.01 
D(V/KLys) 1.3 ± 0.2 2.22 ± 0.03 1.13 ± 0.01 
 
D2O(V) 2.62 ± 0.4 1.6 ± 0.1 1.24 ± 0.03 
D2O(V/KLys) 2.62 ± 0.4 3.8 ± 0.3 1.24 ± 0.03 
 
D2O(V)D 1.8 ± 0.1 2.0 ± 0.6 1.48 ± 0.10 
D2O(V/KLys)D 1.8 ± 0.1 2.0 ± 0.6 1.48 ± 0.10 
 
As stated in methods, the C205S mutant enzyme is the reference for all mutant studies. 
It is also concluded that all mutant enzymes adds in to the C205S mutation. Data were 
obtained in the direction of saccharopine formation at 25°C. Both solvent and multiple 
isotope effects were carried out at pH 7.1. C205S data (K. Bobyk, unpublished data 
from this lab), are included for comparative purposes. 
 
3-4. Discussion 
3-4-1. K99M mutant enzyme 
The mutation of K99 to methionine has omitted a positive charge from the 
active site and resulted in the loss of a side chain that was capable of participating as a 
hydrogen bond donor. In the semi-empirical model (Fig. 3-1), this residue interacts via 
hydrogen bonding with saccharopine and other neighboring residues. Kinetic 
parameters obtained from initial velocity measurements at pH 7 indicate that the 
Michaelis constants for all three substrates have increased. The largest change observed 
is that KLys increased by 900 fold which is the largest increase observed for KLys for a 




V/Et is not significantly affected, the second order rate constants, V2/KLys, V2/KNADH and 
V2/Kα-Kg, have decreased, indicating that binding and perhaps catalysis are affected with 
the mutation. Data suggest that Lys99 as one of the key residues responsible for binding 
and orienting substrate lysine in the active site. In addition to that, decreases observed in 
all of the three second order rate constants reflect, lower specificity of K99M mutant 
enzyme, to its substrates. This suggests that, absence of Lys99 side chain considerably 
affected the binding modes for its substrates in the active site as result of the disturbed 
hydrogen bonding network. 
The kinetic mechanism of SDH in the direction of saccharopine formation at 
neutral pH can be written as shown in mechanism 10. In mechanism 10, A, B, C, P and 
Q represent NADH, α-Kg, Lys, saccharopine and NAD.  The rate constants k1 and k2 
represent binding and dissociation constants of NADH. k3, k4, k7 and k8 and k8 are for 
binding and dissociation of α-Kg, and k5, k6  k9 and k10 are for binding and dissociation 
of lysine, k11 and k12 are the forward and reverse net rate constants for the catalytic 
pathway while k13 and k15 are for the release of saccharopine and NAD, respectively. 
    
 
 





In mechanism 10, k11, the net rate constant for catalysis contains the substrate 
deuterium sensitive step, hydride transfer. A primary deuterium kinetic isotope effect 
maybe observed upon deuteration of NADH at the pro-R hydrogen of C-4 of the 
dihydronicotinamide ring, if the transition state for reduction of the imine (II in Scheme 
3-1) contributes to rate limitation.  The solvent isotope effect reflects protons in flight in 
the transition state for formation of the iminie (II in Scheme 1) from the carbinolamine 
(III in Scheme 1) and to a lesser extent, proton transfer in the transition state for the 
hydride transfer step (3). Multiple isotope effects allow one to determine whether two 
isotope effects reflect the same or different steps and to assess the interrelationship 
between steps if they reflect different steps. 
At pH 7, there is a finite primary substrate kinetic isotope effect of about 2.2 on 
both V and V/K, suggesting that hydride transfer step contributes to rate limitation.  
There is a small (1.6) solvent isotope effect on V, but a large effect (3.8) on V/K.  The 
larger effect on V/K suggests that imine hydrolysis is much slower at limiting lysine 
concentrations while the smaller effect on V suggests that a step(s) other than imine 
hydrolysis, such as the conformational change to open the site and release NAD, 
contributes to rate limitation. On the other hand, if  the isotope effects were measured at 
a pH which is very close to the pKa in the  V/KLys pH-rate profile, it is possible to 
observe  a larger solvent isotope effect on V/K than on V as a result of the equilibrium 
constant  for the acid dissociable group. Multiple isotope effects were measured in D2O 
and H2O using NADD as the deuterated substrate. Effects on both V and V/K are D(V) = 
D(V/K) = 2.06 ± 0.06, and similar to primary deuterium substrate kinetic isotope effect. 







Scheme-3-1. Chemical Mechanism Proposed for Saccharopine Dehydrogenase. 
Michaelis E-NAD-saccharopine complex with NAD and saccharopine bound (I); imine 
intermediate (II); neutral carbinolamine intermediate (III); protonated carbinolamine 
intermediate (IV); protonated carbinolamine intermediate (V); product E·NADH·α-
Kg·Lys complex with a neutral lysine ε-amine (VI); product E·NADH·α-Kg·Lys 






3-4-2. D319A mutant enzyme  
  The active site loses a negative charge as D319 is changed to A. However, the 
only significant change observed at pH 7 was the 72-fold decrease in the second order 
rate constant V/KNADHEt resulting 23-fold increase in KNADH. None of the other kinetic 
parameters including the kcat changed significantly. This mutant exhibited the largest 
effect on KNADH, observed thus far for SDH (11). Data suggest that D319 is involved in 
binding NADH in the active site.  On the basis of the semi-empirical model, the 
carboxamide side chain of the nicotinamide donates a hydrogen bond to the side chain 
carboxylate of D319A, providing binding energy for NADH. 
The V/Et pH- rate profile is similar to that of the C205S mutant enzyme. There 
are two active enzyme forms, one active at low pH and the other active at high pH. 
When the pH was increased, the Vmax decreases from higher pH independent value to a 
lower one at high pH. V/KNADHEt decreases at low and high pH, giving pKa values of 
5.9 and 9.1. The group with a pKa 5.9 is absent in C205S. This group might be D227 
which is within hydrogen bond distance to the adenine ribose, and is known to be 
important for binding NADH. The group with a pKa 9.1 is likely an arginine or a lysine 
side chain in the vicinity of the pyrophosphate back bone,  that must be protonated for 
optimum binding of NADH. The V/KLysEt pH-rate profile of D319A, is similar to that 
of C205S, but the pKas of the two binding/catalytic groups are perturbed to lower and 
high pH, by about 1 pH unit, suggesting that the carboxylate side chain of D319A, helps 
to adjust the pKas of binding/catalytic residues.  
A dead-end inhibition pattern by OG vs NADH, was measured at pH 6, to 




OG gives uncompetitive inhibition, indicating that OG, and by analogy, α-Kg binds 
after NADH, consistent with the kinetic mechanism of the WT-SDH.  
Isotope effects were measured for D319A. Although values of the primary 
deuterium, solvent deuterium and multiple isotope effects are finite, they are small, and 
the thus hydride transfer and hydrolysis of imine, do not contribute much to the rate 
limitation of the mutant enzyme compared to wild type. Data suggest that some isotope 
insensitive step, such as substrate binding or a conformational change to close the site 
for reaction or open the site to release products, may contribute more to rate limitation 
of this enzyme.  The multiple isotope effect D2O(V/K)D is a little higher than the solvent 
isotope effect (D2O(V/K)) suggesting hydride transfer is slower of the catalytic steps and 
imine hydrolysis is not as slow.  
 
3-5. Conclusions 
Data obtained for K99M and D319A, support their role in binding substrates. On 
the basis of location of K99, in the semi-empirical ternary complex (Figure 3-1), it acts 
as a hydrogen bond donar, and make several H-bonding interactions to Glu122, as well 
as the carboxylates of the saccharopine molecule. Once the Lys99 side chain is no 
longer there, these interactions are disturbed, making it difficult for the substrates to 
bind and orient properly, in the active site. This is reflected in the decreased second 
order rate constants and the increased Km values for all three substrates. It is evident that 
K99 contributes to a H-bonding network, that is important for the overall SDH reaction. 
D319 on the other hand, plays a key role in binding the dinucleotide substrate in its 
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Overall discussion and conclusions 
This course of study focused on the enzyme saccharopine dehydrogenase from 
Saccharomyce cerevisiae, in order to obtain a detailed understanding of the overall 
significance of charged residues in the active site in order to establish a detailed 
mechanism for SDH.  
Saccharopine dehydrogenase (L-lysine forming); (EC 1.5.1.7) catalyses the final 
step of the α-aminoadipate pathway, the reversible pyridine nucleotide-dependent 
oxidative deamination of saccharopine using NAD as the oxidizing agent, to produce α–
ketoglutarate (α-Kg) and lysine. (1). On the basis of pH dependence of kinetic 
parameters, isotope effects and the dissociation constants for inhibitors, a two base 
chemical mechanism has been proposed for this enzyme. In the direction of 
saccharopine oxidation, once NAD and saccharopine are bound, a group with a pKa of 
6.2 accepts a proton from the secondary amine of saccharopine resulting in formation of 
an imine.  The imine is hydrolyzed via general base catalyzed activation of a water 
molecule, and the intermediacy of carbinolamine intermediates.  The base participating 
in the hydrolysis reaction has a pKa of 7.2.  Finally, the ε-amine of lysine is protonated 
by the conjugate acid of the base with a pKa of 6.2, and products are released (2, 3, 4).  
Isotope effects suggest hydride transfer, proton transfer and hydrolysis of the imine 




pH-rate profiles revealed a group that has a pKa of about 6-7 that must be 
unprotonated to bind lysine or saccharopine but should be protonated for binding of 
Leu,  which is a competitive inhibitor vs. Lys (3). Data suggested a neutral acid (Asp or 
Glu) is in the vicinity of the ε-amine of Lys or the secondary amine of Sacc. There was 
no structural information available at this time when the hypothesis was put forward.  
Later, structures of SDH were solved in the apo-enzyme form (5) and with either 
AMP or oxalylglycine (OG), analogues of NAD and α-Kg, bound (4). A semi-empirical 
ternary complex structure of the E·NAD·saccharopine ternary complex was generated 
on the basis of E·AMP and E·OG structures (4). Given the semi-empirical nature of the 
model, the relative positions of reactants and active site groups are estimates, and the 
overall model represents an open form of the enzyme. There are a number of ionizable 
residues in the active site, and a multiple sequence alignment of the SDH from Candida 
albicans, Aspergillus fumigates, Saccharomyces cerevisiae, Pichia guilliermondii, and 
Cryptococus neoformans indicated all are conserved in all five organisms, suggesting 
their importance in the mechanism. So we hypothesized that all charged residues 
contribute to the overall SDH reaction.  
In the proposed model, E78 and E122 are in the vicinity of the secondary amine 
of saccharopine and both residues are completely conserved. One of these was a 
candidate for the neutral acid described above (3) and E78 and E122 were in position to 
act as one of the general bases in the chemical mechanism. Therefore, we selected these 
two residues for mutagenesis. In the ternary complex, there are three lysine residues, 
K99 in the vicinity of the α-carboxylate of saccharopine, three glutamates, E122 near 




of NAD+ is positively charged, but in the vicinity of D319, and the secondary amine of 
saccharopine is positively charged given its pKa of about 10 (3).  The active site is 
positively charged, and any changes on any of these residues was expected to affect the 
pKa values of all of the ionizable residues in the site including the catalytic residues. 
Our long-term goal is to obtain an estimate of the contribution of each of the residues in 
the active site to reactant binding and catalysis, directly or indirectly. 
To test the hypothesis, in this study, E78, E122, K99 and D319, were mutated 
by site directed mutagenesis to produce E78Q, E122Q, E78A, E122A, E78Q/E122Q 
E78A/E122A, K99M and D319A. Disulfide bond formation has been observed between 
C205 and C249 rendering nearly 60-80% of the enzyme inactive, because the disulfide 
bridge blocks the binding pocket for NAD or NADH (4). Therefore K99M and D319A 
mutant enzymes were prepared in the C205S background, which eliminates disulfide 
formation, so that 100% of the enzyme is in the “reduced” active form.  By changing 
glutamates to Q, the negative charge was removed from the active site, still allowing it 
to make hydrogen bonds. However, changing them to A, shortened the side chain and 
abolished the ability to make hydrogen bonds. The active site loses a negative charge as 
D319 is changed to A. The mutation of K99 to methionine has omitted a positive charge 
from the active site and resulted in the loss of a side chain that was capable of 
participating as a hydrogen bond donor. All mutant proteins were cloned, expressed, 
purified and characterized and the data were interpreted in this dissertation.  
 
4-1. Kinetic mechanism and substrate binding 




lysine formation with NAD bound before saccharopine, while in the reverse reaction 
direction NADH binds to E, but lysine and α-Kg bind in random order (2).  In addition, 
above pH 8 the mechanism in the reverse reaction direction changes to ordered with α-
Kg binding after NADH and before lysine (3).  With the exception of the E78A mutant 
enzyme, data indicate the kinetic mechanism of all mutant enzymes is the same as WT. 
Most changes are small, but those for V/KLys are considerably larger for the E122Q, 
E122A, and the double mutant E78Q/E122Q and the largest for E78A/E122A and 
K99M. Changes in V are small (<5-fold being the highest observed), but high values of 
KLys were observed, suggesting K99M and E122 play a major role in lysine binding. 
Similarly, both glutamate double mutants and K99M exhibited lower V/Kα-KgEt for α-
Kg, although they were not as high as the differences observed for those of Lys.  
Differences observed suggest that E122 and K99 are important for optimum binding of 
lysine, α-ketoglutarate and saccharopine in the active site. For K99M, all three second 
order rate constants decreased suggesting that the affinity of enzyme for all three 
substrates were lower. Data suggest that the absence of the Lys99 side chain 
significantly affected the binding modes of substrates in the active site as result of the 
disturbed hydrogen bonding network. The D319A mutant enzyme exhibited significant 
decreases in the second order rate constant V/KNADHEt resulting in a 23-fold increase in 
KNADH. This mutant exhibited the largest effect on KNADH, observed thus far for SDH (6) 
suggesting that the major role of D319 is binding NADH in the active site.  On the basis 
of the semi-empirical model, the carboxamide side chain of the nicotinamide donates a 





4-2. pH-rate profiles 
There were no significant differences observed in the pH-rate profiles compared 
to those of wild type SDH. However, the log V/KLysEt profiles of E78 and E122 mutants 
indicated that, with the absence of negative charge on the side chain carboxylates, the 
two catalytic groups observed in the wild type V/KLysEt profile, were perturbed more 
than 1.5 pH units apart from each other. This clearly showed that these residues were 
important for maintaining the pKa of the catalytic residues near neutrality.  
 
4-3. Isotope effects 
All mutant enzymes contributed to hydride and proton transfer steps. The 
hydride transfer step was the slowest in the E to A double mutant enzyme, suggest that 
both E78 and E122 make significant contribution significantly to an efficient transfer of 
H- in the chemical step. For E to Q mutant enzymes, multiple isotope effects were 
smaller than the solvent isotope effect on V and V/K, suggesting hydride transfer and 
proton transfer occur in two different steps. Hydride and proton transfers contributed 
least to the rate limitation of the D319A mutant enzyme, indicating this residue is not 
significant for the chemical reaction. Probably a conformational change required to bind 
the reactants or to open up the enzyme to release products likely contributes to rate 
limitation of the D319A mutant enzyme. The K99M mutant enzyme exhibits V/KLys > V, 
suggests that conformational change is likely to contribute more to rate limitation than 
the chemistry. 
All residues are likely responsible for more than one function in the active site.   




organized back-up system. It has the ability to carry out the reaction even in certain 
defective conditions. Mother-nature has designed this system to ensure lysine 
production. The most likely reason for this may be because SDH is the last enzyme in 
the pathway. Lysine is an essential amino acid, and also the feed-back inhibitor for the 
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Figure I-1. Sequence alignment of the active site residues of Saccharopine 
dehydrogenase from five different organisms. 
 
 
This is a sequence alignment of the active site residues of SDH from Candida 
albicans, Pichia guilliermondii, Saccharomyces cerevisiae, Aspergillus fumigatus, and 
Cryptococcus neoformans. All the active site residues are conserved and most of the 







APPENDIX - II 
 
Determination of synergestic effects from catalytic (K77 and H96) and 




Proposed chemical mechanism (1) suggests a two base mechanism, one is to 
abstract a proton from the secondary amine of saccharopine and the other is to activate a 
water molecule for the imine hydrolysis. Recent site directed mutagenesis studies1 (2) 
on the active site residues of SDH, from S cerevisiae and have identified K77 and H96Q 
as the catalytic residues (K77 as the base that abstracts a proton from the secondary 
amine of saccharopine and H96 as the base that activates a water molecule in the imine 
hydrolysis step1) as they exhibited the largest primary substrate kinetic and solvent 
isotope effects respectively. E78 and E122 were recognized as binding residues mostly 
for lysine and for α-ketoglutarate and as modulators of the acid-base catalysts, by 
bringing the pKa of the catalytic residues to near neutrality (2). Structural data revealed 
C205 and C249 involved in disulfide bond formation and by mutating C205 to serine, 
the disulfide bond formation was disabled as a result the enzyme was able to purify in 
100% active form (3)   
Based on the above informatin, we were enthusiastic to investigate the mutual 
effects of both catalytic and binding residues and their synergetic effects on the overall 
reaction, if they are absent in the active site. In this manuscript we present the 
synergetic interaction of catalytic residues K77 and H96 with one of the acid base 




H96Q/E122A were prepared by site directed mutagenesis, in C205S background (3) and 
were completely characterized and the data are interpreted in terms of the proposed 
chemical and kinetic mechanisms. 
 
Materials and methods 
 Materials used were as same as mentioned in chapter 2 and 3. Site-directed 
mutagenesis was performed on the K77M/C205S and H96Q/C205S plasmids using the 
primers used to generate E122A plasmid (2), in order to generate K77M/E122Q/C205S 
and H96Q/E122A/C205S. Both mutant proteins K77M/E122A and H96Q/E122A, were 
expressed at 16 °C, overnight (16-20 hrs).  Initial velocity patterns, pH profiles and 
isotope effects data were obtained as same as mentioned in chapters 2 and 3. 
 
Results  
Mutant proteins were expressed well as same as the wild type. They were 98% 
pure and sufficiently active under the conditions and the pH-range employed. 
 
Initail velocity data 
Double reciprocal initial velocity patterns were obtained at pH 7.2 in the 
direction of saccharopine formation. For the K77M/E122A mutant enzyme, Lys/α-Kg 
pair exhibited a pattern which intersected to the left of the ordinate. The α-Kg/NADH 
pair exhibited a pattern that intersects on the Y axis at very high NADH concentrations 






Figure II-1. Double reciprocal plot of initial rate as a function of the concentration of 
α-Kg, shown at different fixed levels of NADH, 0.01 mM (♦); 0.015 mM (●); 0.03 mM 
(▲); and 0.58 mM (■).  The concentration of Lys was fixed at 70 mM (saturation). 
Points are experimentally obtained values.  
 
The kcat for K77M/E122A decreased more than 1200-fold. Second order rate 
constants with respect to Lys decreased nearly 12000- folds. Both V/K for α-Kg and 
NADH decreased more than 1000- and 7000- fold. For H96Q/E122A mutant enzyme, 
Michaelis constants for KLys, KNADH and Kα-Kg increased 280-, 63- and 148- fold, 
respectively. V2/KLysEt decreased more than 600- fold, while the V/KEt for α-Kg 
decreased at least 300- fold. The kcat did not change for H96Q/E122A. Kinetic 





Table II-1. Summary of the kinetic parameters obtained for K77M/E122A and 
H96Q/E122A mutant enzymes. 
  
Kinetic parameters 




V2/Et (s-1) (1.06 ± 0.02)×102 0.087 ± 0.004 48.04 ± 0.98 
Fold change  -1218 -2.2 
V2/KNADHEt (M-1s-1) (1.1 ± 0.2)×10
7
 (8.7 ± 0.05)×10
3 (7.60  ± 0.1)×104 
Fold change  -1264 -144 
V2/KLysEt (M-1s-1) (1.2 ± 0.1)×10
5
 (10.12 ± 0.86) (1.91 ± 0.07)×10
2 
Fold change  -11857 -630 
V2/Kα-Kg Et (M-1s-1) (9.7 ± 0.6)×10
5
 (1.38 ± 0.27)×10
2 (3.0 ± 0.03)×103 
Fold change  -7029 -323 
KNADH (mM) 0.010 ± 0.002 0.010 ± 0.007 0.63 ± 0.02 
Fold change  1 + 63 
KLys (mM) 0.11 ± 0.01 8.6 ± 0.8 251 ± 4 
Fold change  +10 +282 
Kα-Kg (mM) 0.9 ± 0.1 0.63 ± 0.15 16.3 ± 0.1 
Fold change  +6 +148 
 
Kinetic parameters for K77M/E122A and H96Q/E122A mutant enzymes, in the 
direction of saccharopine formation at 25°C and pH 7.2. The C205S mutation is 
included in both K77M/E122A and H96Q/E122A.  C205S is the reference teherfore 




K77M/E122A exhibited small primary substrate and solvent kinetic isotope 





Table II-2: Summary of the isotope effects for K77M/E122A and H96Q/E122A. 
 
Kinetic parameters C205S K77M/E122A H96Q/E122A 
 
D(V) (pH9) 
1.3 ± 0.2 
 
1.65 ± 0.08  
 
ND 
D(V/KLys) 1.3 ± 0.2 1.21 ± 0.1 1.2 ± 0.2 
 
D2O(V) 2.62 ± 0.4 2.13 ± 0.07 ND 
D2O(V/KLys) 2.62 ± 0.4 2.23 ± 0.15 2.07 ± 0.02 
 
D2O(V)D 1.8 ± 0.1 1.77 ± 0.05   ND 
D2O(V/KLys)D 1.8 ± 0.1 3.08 ± 0.2 ND 
 
 
C205S mutant enzyme is the reference for all mutant studies. It is also concluded that 
all mutant enzymes adds in to the C205S mutation. Data were obtained in the direction 
of saccharopine formation at 25°C. All isotope effects were measured for K77M/E122A 
at pH 8.2. For H96Q/E122A, substrate isotope effects were measured at pH 7.2 while 
solvent effects were measured at pH 5.3 C205S data are included for comparative 
purposes (3). Since limiting substrate concentrations were used, Vmax could not be 





The highest pH independence value of the log V/Et profile is 0.71 ± 0.03 s-1. The 
partial changes observed in the middle of the profile is due to two groups important but 
not essential for catalysis.  There are two pH independent regions in the log V/KlysEt 
profile. At low pH, the pH independent value decreases from 6.5 ± 0.1 to a value of (-) 
0.40 ± 0.04 M-1 s-1.  At high pH, the curve is bell-shaped and the highest pH 







Figure II-3. pH Dependence of Kinetic Parameters for the K77M/E12A mutant 
Enzyme in the Direction of Saccharopine Formation.  Data were obtained at 25oC for 
V2/Et (A), V2/KLysEt (B) and V2/Kα-KgEt (C).  The points are the experimentally 
determined values, while the curves are theoretical based.  
 
 
independent value of 6.5 M-1 s-1 and the highest pH independent region.  In the V/KLys 
profile, there are three groups important for binding and catalysis, one at pKa 5.12 ± 
0.02, the other two groups have pKas at 7.3 ± 0.06 and 8.98 ± 0.07. The log V/Kα-KgEt 




0.04, which is important but not essential for binding and/or catalysis and a group with 
pKa 9.17 ± 0.06 at high pH which is essential for binding α-Kg to the enzyme. The 
highest pH independent value observed was 102.1 ± 3.9 M-1s-1. 
The pH dependence of the kinetic parameters were not measured for 
H96Q/E122A mutant enzyme as Km for Lys and NADH were high and as a result, 
saturating conditions were not able to achieve. pH-rate profiles of K77M/E122A are 
consistent with the initial velocity data. A hollow observed in the V/KLys profile is due 




The initial velocity pattern exhibits a curvature as α-Kg concentration is 
increased.  There are several possibilities for this pattern. One possibility is, there are 
two different forms of enzyme, having two different affinities for the substrate α-Kg. 
Another possibility is the enzyme is in steady state although the rates are more than 
1200-fold lower. Also it is possible that there are two different pathways for the 
reaction and they take place under two different α-Kg concentrations. At high α-Kg 
concentrations, α-Kg binds to free E, before NADH adds and it is going to be the faster 
pathway. In that case, Lys binds to the E·α-Kg·NADH complex. Large decreases in kcat 
for K77M/E122A suggests that catalysis is remarkably decreased and K77 is an 
important general base for this reaction. Decreases in all second order rate constants are 
consistent with the catalytic role of K771, and binding and modulating the basicity roles 
of E122. High Km values observed for Lys and NADH in H96Q/E122A suggests that 




still contributes to rate limitation but to a lesser degree than that observed in 
K77M/C205S mutant enzyme (4.9) (unpublished data) 
Solvent isotope effects suggest that proton transfer also contributes to rate limitation.  
Larger V/KLys than V observed in multiple isotope effects suggests that some 
conformational change requires to bind lysine or to release products, contributes more 
to rate limitation. Primary substrate and solvent isotope effects suggest that it is likely a 
structural change occurred with these two mutations, and as a result, a conformational 
change may be the slow step for this reaction, other than the chemical step. In 
H96Q/E122A mutant enzyme, only proton transfer contributes to rate limitation. 
Hydride transfer is no longer slow but it is possible that a conformational change(s) 
contributes to rate limitation of this enzyme. From the data available, it is reasonable to 
conclude that, the effects observed when both binding and catalytic residues are absent 
simultaneously, the changes observed are not additive, but more of synergestic effect on 
the overall reaction.  
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Human salivary peptide Histatin-5, subcloning, expression, 
purification and metal ion binding studies 
Background and significance 
 Histatins (hists) are a class of cationic, histidine-rich, salivary peptides 
which are basic due to the high content of basic amino acids arginine, histidine and 
lysine (1, 2). They are composed of a family of at least 12 low molecular weight short 
peptides (see Table III-1) (3). Hist-1, hist-3 and hist-5, which contain 57, 51 and 24 
amino acids respectively are the most abundant in human saliva (4). Hist-5 is a 
proteolytic product of hist-3 and its molecular weight is about 3037 Da (5). In healthy 
adults, the concentration of hists in saliva is 15-30 µM (1, 3).  All hists are structurally 
related. HTN1 and HTN3, are the genes which code for the precursor proteins histatin-1 
and 3, and are located on the 4q13 region of human chromosome 4.  Other histatins are 
produced by proteolytic degradation of hist-1 and 3. Histatins are found only in salivary 
secretions of higher primates like humans and some old world monkeys such as Macaca 
fascicularis but are not present in new world monkeys or any other primates (6).  
 
Antimicrobial properties of histatins  
Histatins exhibit a wide range of cidal activity against a broad spectrum of 
pathogenic fungi including Candida albicans, Candida glabrata, Candida krusei, 
Candida dublinensis and Cryptococcus neoformans and exhibit bactericidal properties 




5 is the most powerful member that kills pathogenic Candida cells up to 90-100%, 
inhibiting the conversion of the non-infective vegetative form to the infective 
germinated state of Candida albicans (7, 12). Histatins also exhibit cidal activity against 
Streptococcus mutans, inhibit the cystein protease clostripain from Clostridium 
histolyticum, and neutralize the leukotoxin elaborated by the periodontal pathogen 
Actinobacillus actinomycetemcomitans (13). Conidia of the pulmonary pathogen 
Aspergillus fumigatus show a greater susceptibility to hist-5 than amphotericin-B (4, 8-
9). Histatins are active against fungi that are resistant to conventional azole and polyene 
drugs (7). These peptides may therefore assist innate resistance to oral infections (2). 
Recent studies have demonstrated that azole drug resistant Candida species are 
susceptible to histatins, suggesting a different mechanism of action from that of the 
azole-based antifungal drugs (7, 10). Localization studies have shown that hist-5 can 
translocate across the cytoplasmic membrane of C. albicans. Once it is in the cytosol, it 
targets mitochondria and then consumes mitochondrial transmembrane potential, 
destroying mitochondrial function, by a direct or indirect mechanism (3). Their potent 
antifungal activity, lack of toxicity to humans and the ability to kill azole resistant yeast 
strains make them potential candidates for drug therapy and templates for drug design 
(3, 7).   
Structure and function 
Histatins have unique structural features such as low molecular weight, cationic, 
high histidine content, lack of disulfide bonds and weak amphipathic character of the α-




dichroism (CD) and NMR spectroscopy (15), show the fragment from residues 9-24 of 
hist-5 prefers a random coil conformation in aqueous solutions like DMSO and water. 
In organic solvents such as TFE (Trifluoroethanol), the α-helical conformation is 
preferd. Though the α-helical structure was thought to be important for the mode of 
action of hist-5, it has been observed that the hist-variants with the reduced ability to 
form α-helices possessed antifungal activity comparable to that of hist-5 (9). 
 
Histatin metal ion binding and generation of reactive oxygen species (ROS) 
High histidine content in histatins suggests the ability to complex with metal 
ions, particularly transition metals ions such as Cu [Cu (I), and Cu (II)], Fe, Zn and Ni. 
The peptide conformation may greatly be influenced by the formation of stable hists-
metal complexes which in turn may play a significant role in their biological activity 
(15).  Hist-5 contains the structural motif His-Glu-X-X-His for zinc binding and 
contains two repetitive His-X-X-X-His “motif” in its sequence for copper binding. An 
additional motif (N-Asp-Ser-His) for interacting copper and nickel, known as ATCUN 
is also present in hist-5 (16, 17). It is believed that metal binding ability of hists are 
important to their biological activity because it sequesters the ions necessary for 
microbial survival. Binding of metal ion may alter the peptide to a biologically active 
conformation (18).  
The generation of ROS has also been associated with histatins. The 
mitochondria of C. albicans can generate ROS, depending on morphogenesis, and the 
highest levels of ROS are found in cells with hyphal forms. In biological systems these 

















                         
Peptide 
Name 
Amino acid sequence No: of 
amino acids 
Histatin 1 MKFFVFALVLALMISMISADSHEKRHHGYRRKFHEKHHSHREFPFYGDYGSNYLYDN 57 
Histatin 2 …………………………………………………...RKFHEKHHSHREFPFYGDYGSNYLYDN 27 
Histatin 3 MKFFVFALILALMLSMTGADSHAKRHHGYKRKFHEKHHSHR………G...YRSNYLYDN 51 
Histatin 4                                                                                RKFHEKHHSHR . . . . . . G...YRSNYLYD 21 
Histatin 5                                                  DSHAKRHHGYKRKFHEKHHSHR……....G   Y   24 
Histatin 6                                                  DSHEKRHHGYKRKFHEKHHSHR……..G…YR 25 
Histatin 7 ……………………………………………………RKFHEKHHSHR……...G...Y 13 
Histatin 8 ……………………………………………………  KFHEKHHSHR……...G...Y 12 
Histatin 9 ……………………………………………………RKFHEKHHSHR……...G..YR 14 
Histatin 10 ……………………………………………………  KFHEKHHSHR……  G…YR 13 
Histatin 11 …………………………………………KRHHGYKR 8 




However, the specific ROS species produced, the role of metal ions in their 
production, and whether the oxidative stress is causative or symptomatic of the 
biological activity, the connection between the bio-activity of the histatins, metal ion 
binding, and ROS production, are not well established.  
This project would addresses significant structure/activity issues of this bio-
active, histatin-5 establishing the structure and stability of Cu (I, II)-hists  complexes, 
including determination of L/Cu composition. The primary goal was to determine the 
stoichiometry between Cu (I, II) and hists  complexes using isothermal titration 
calorimetry (ITC). 
 
Materials and methods 
PTYB1 vector, NdeI, SapI and BspEI restriction enzymes and the Chitin-affinity 
resin were from New England biolabs (NEB). cDNA of HTN3 gene was from ATTC.  
PCR reaction components were from invitrogen.   
Methods and Results 
a) Sub-cloning of Histatin-5 gene sequence into pTYB1 vector 
cDNA of HTN3 which codes for histatin 3, was purchased from ACCT. Then 
primers were designed to amplify the DNA segment that codes for histatin 5 peptide, 
using PCR. The primers were designed to have sticky ends by introducing NdeI and 
SapI restriction sites, to the forward and reverse primers respectively. A successful  
PCR-amplified histatin 5 DNA fragment assessed on an agarose-gel (Fig.II-1). After 
several attempts, the ligation of PCR-amplified histatin-5 gene into the multiple cloning 




of the sizes of the vector (7477 bp) and the insert (72 bp). Next approach was to use a 
larger insert instead of ≈ 72 base pair insert. The the primers were designed including 
hists-5 gene sequence, in such a way that it will amplify up to the BspEI restriction site 
of the pTYB1 vector (Figure III-2). 
 
Figure III-2. Complete pTYB1 vector map showing the restriction sites and the 
functional segments. Yellow color indicates the restriction sites in either sides of the 
new insert. (extracted from NEB- catalog-2006) 
 
 
In the new approach, the primers were designed to have Nde1 and BspEI, because the 
vector fragment from pTYB1 also contained these two restriction sites at either ends. 
Then the same PCR program was used to amplify the bigger DNA-insert carrying the 








Figure III-1. Agarose gel used to determine the success of the PCR reaction and to assess the concentrations of the 
vector and the insert for ligation step.  A) PCR amplified DNA of histatin-5 gene.  B) Double digested pTYB1 vector 








Figure III-3. A schematic representation of  the new approach for amplifying a longer 
DNA- fragment together with the hist-5 DNA sequence. Arrows indicate the forward 
and reverse primers. Forwatd primer carries the Hist-5 gene sequence in it. Reverse 






Figure III-4. Agarose-gel picture showing the digeted fragments of the pTYB1 vector 
ligated with the longer DNA fragments. Both DNA fragments are located exactly where 





Protein expression and purification 
Once the ligation was successful and the sequence was correct, the pTYB1–
ligated plasmid was transformed into BlL21(DE3)Ril Escherichia coli strain. Cells were 
grown in LB medium at 37°C, overnight  in the presence of Ampicillin and 
Chloramphenicol antibiotics. When OD was nearly 0.8, the cells were induced with  ≤1 
mM IPTG and expressed for 4 hours at 27 °C. Cells were lysed by sonication. The 
expressed hist-5 peptide, with the C-terminal intein-affinity tag, was purified using 
chiting-binding resin. (Figure II-6).  
 
Figure III-6. A schematic diagram of the thiol-mediated purification of C-terminal  
intein tagged-histatin-5 short peptide. Chitin resin is indicated as blue ovals bound to 
the vertical axis. CBD is the chitin binding domain, and it is fused to the intein protein 
(green). Hist-5 (orange) is fused to the N-terminal of the intein protein. Dithiothritol 
(DTT) or β-mercapto ethanol can induce the cleavage of thioester bond between the 
hist-5 and the intein protein by varying the temperature, or pH. Target protein, hist-5 is 





                          




Optimizing the thiol mediated on-column cleavage of hist-5  
        
Figure III-7. 15 % SDS-protein gel, showing the cleaved peptide from the chitin 
column at different temperatures indicated above the gel-image. The intensity of the 
hist-5 peptide bands are directly proportional to the  amount of cleavage. The incubation 
temperatures of 75° and 95°C do not contain any impurities, and have cleaved equal 




Figure III-8. 15% SDS-protein gel, showing the cleaved peptide from the chitin 
column, when incubated at 75 °C for 5, 10 and 15 minutes. The loading buffer for the 
SDS-gel, was prepared with/without SDS and the blue dye (bromophenol blue). In the 
samples containing the SDS and the blue dye, the larger protein bands can be seen, but 
hist-5 is absent. The samples did not have SDS, show very little contamination and hist-




Once the crude protein was added to the column, the column was washed well 
with sonication buffer and added the cleavage buffer (100mM HEPES, pH 7.5, 300mM 
KCl and 50 mM DTT). The entire column was then incubated at several different 
temperatures for maximum of 15 minutes and the equal volumes of the incubated 
samples were ran on a 15% SDS-gels to determine which temperature gave the highest 
yield of hist-5 peptide  (Figure II-7). After the optimum temperature which yielded most 
of the peptide  was determined, a few samples were incubated at three different time 
courses to determine the best time course for incubation, which may result optimum 
cleavage as well as prevent denaturing the chitin resin. Once the peptide is collected this 






Figure III-9. 12% SDS-gel showing fractions from each step of the optimized column 
purification protocol. Last two columns show histatin samples, which were cleaved at 













Figure  III-10. Histatin-5 absorbance patterns at different pH and at 25°C.  
 
 




Figure III-11. UV-Vis spectrophotometric titrations of histatin-5 with Cu2+ (using 




histatin concentration was 45.87 uM. The absorbance of the histatin-5 changed 





24 amino acid, short peptide histatin-5 was subcloned and  expressed in E. coli, 
successfully.  The optimized purification protocol resulted in a high yield. These 
thermally cleaved histatins were stable over a wide temperature range.  
Some metal ion studies were carried out with Cu2+, Ni2+, and Fe3+ using UV-vis 
spectroscopy (Data obtained for fe and Ni are not shown. Titration of histatin-5 with 
Cu2+ showed 1:1 binding stocheometry. This is similar to the experimentally determined 
value using ITC. The dissociation constant calculated using these data was  53.16 uM 
which is closer to the experimentally obtained valu of 38 uM (with ITC). More 
thermodynamic parameters and metal ion titrations would be determined with histatin -
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LIST OF ABBREVIATIONS 
 
 
AAA   α-aminoadipate pathway 
AAT  α-aminoadipate-aminotrasferase 
AAR   α-aminoadipate reductase 
AAS   α-aminoadipate-δ-semialdehyde 
AMP  Adinosine mono phosphate 
α-Kg   α-ketoglutarate  
Ches  2-(N-cyclohexylamino)-ethanesulfonic acid 
DAP  Diaminopimelic acid pathway  
DCl  deuterium chloride 
D2O  deuterium oxide  
DTT  Dithiothritol 
E  Free enzyme form 
HCS  Homocitrate synthase 
IPTG   isopropyl β-D-1-thiogalactopyranoside  
ITC  Isothermal titration calorimetry 
LB             Luria-Bertani 
Mes  2-(N-morpholino)-ethanesulfonic acid monohydrate  
NAD+ nicotinamide adenine dinucleotide  
NaOD  sodium deuteroxide 




NADD reduced nicotinamide adenine dinucleotide with deuterium in the 4R 
position  
Ni-NTA  nickel-nitrilotriacetic acid 
OG  Oxalylglycine 
PCR   polymerase chain reaction 
PMSF   phenyl-methanesulfonyl fluoride  
ROS  Reactive oxygen species 
SDH   saccharopine dehydrogenase 
SDS-PAGE  sodium dodecyl sulfate polyacrylamide gel electrophoresis 
Taps   [3-N-tris(hydroxymethyl)methyl]-3-amino-propanesulfonic acid  
TCA  Tricarboxyilic acid 
UAS   Upstream activating sequence 
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